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Embryonic stem (ES) cells have the ability to maintain pluripotency and selfrenewal during in vitro maintenance, which is a key to their clinical applications. ES cells
are a model in developmental biology studies due to their potential to differentiate in
vitro. Understanding critical pathways of pluripotency, self-renewal, and differentiation
during early embryonic development is important for the evaluation of the therapeutic
potential of ES cells because of their ability for tumor transformation due to genetic and
epigenetic instability acquired during in vitro culture maintenance. Single tandem repeats
are sequences of DNA that have been implicated in the deregulation of gene expression
in different human conditions. Understanding the origin of repetitive sequence instability
and functions in the genome allow characterization of early genomic instability signals in
ES cell pluripotency, differentiation, and tumor transformation pathways. The hypothesis
of this study was that genetic stability, in repetitive sequences, located near embryonic
developmental genes is responsible for pluripotency, self-renewal, differentiation, and
chromatin assembly and could be a signal for adaptation, differentiation, or
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transformation of ES cells in vitro. Our result showed instability in specific repetitive
sequences which increased during ES cell passages and embryoid body differentiation in
vitro. ES cells displayed significant mean frequencies of genomic instability in repetitive
regions that lead to ES cells pluripotency, self-renewal maintenance, or cell lineage
specialization. The present study reports potentially biomarkers for identifying
accumulation of genomic instability in specific genes that may contributes to adaptation
of ES cells and could be the switch that initiates early ES cell lineage commitment in
vitro. Determining genetic and epigenetic modifications, including single tandem repeat
instability, gene expression changes, and chromatin modifications, is essential for
elucidating possible molecular mechanisms of genomic instability and determining novel
molecular characterization for diagnostic purposes to ensure ES cell stability and
integrity that could potentially lead to use of ES cell derivatives that could then be a safe
source needed for regenerative medicine applications.
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CHAPTER I
INTRODUCTION
Genetic and epigenetic developmental processes regulate pluripotency and
differentiation in embryonic stem (ES) cells in vivo and in vitro. ES cells are pluripotent
and are derived from the inner cell mass of blastocysts. ES cells are distinguished from
other cell types by the following special characteristics: they can be maintained in an
undifferentiated state during extended culturing over time, and they have the capacity to
differentiate into every cell type in the body (Evans and Kaufman 1981). There have
been remarkable breakthroughs in science over the last 20 years that have resulted in
defined culture conditions for reproducible in vitro culture systems for ES cell
maintenance (Thomson et al. 1998; Amit et al. 2000; Takahashi and Yamanaka 2006; Yu
et al. 2007; Yu et al. 2009; Ohta et al. 2011). More recently, the developmental potential,
including culture conditions and growth factors required to direct the in vitro
development of these cells down tissue specific pathways for the purpose of regenerative
medicine, have been under study (Xu et al. 2001; Ogawa et al. 2006; Bigdeli et al. 2008;
Cordes et al. 2009; Takemoto et al. 2011). Initially, ES cells were established in coculture with a mouse embryonic feeder layer (MEF) (Evans and Kaufman 1981;
Thomson et al. 1998). Later, nutrient requirements for culture became more specifically
characterized after the discovery of particular growth factors derived from the feeder
layer. Leukemia inhibitory factor (LIF) is a growth factor derived from the feeder layer
that maintains the characteristics of pluripotency and self-renewal in ES cell culture (Xu
1

et al. 2001; Ogawa et al. 2006). ES cells can now be maintained on a feeder layer in
serum free medium supplemented with basic fibroblast growth factor (bFGF) and LIF
(Brimble et al. 2004). ES cells can now also be cultured in the absence of feeder cells if
they are cultured on matrigel or laminin coated plates in media supplemented with
conditioned media from MEF (MEF-CM) (Bigdeli et al. 2008).
Some reports show that ES cells cultured in these conditions for more than 100
passages are still able to maintain chromosomal stability and the capacity for
differentiation into the three basic embryonic germ layers (mesoderm, ectoderm, and
endoderm) in vitro as embryoid bodies (Amit et al. 2000) or in vivo as a teratoma (Evans
and Kaufman 1981; Thomson et al. 1998; Mitalipova et al. 2005; Kamiya et al. 2011).
Adaptation, survival, and growth of ES cells in vitro are facilitated by genomic
instability. ES cells in culture, during late passages, show a higher genomic instability
frequency than earlier passages. Genomic instability is characterized by overlapping in
numerical chromosomal alterations (up to 45%), mitochondrial DNA mutations (up to
22%), and modifications on promoter gene methylation (up to 90%) (Maitra et al. 2005).
Differences in the plasticity and ability for in vitro adaptation of ES cell lines is a result
of incremental changes in genomic instability frequency leading to cellular and molecular
modifications; this is frequently displayed as a proliferative advantage in late passages
in contrast to early passages which are genetically and epigenetically stable (Inzunza et
al. 2004; Allegrucci et al. 2007). Cellular adaptation resulting from genomic instability
includes karyotype abnormalities, failure in X-inactivation, and epigenetic modifications
that lead to imbalances between self-renewal and differentiation signals during in vitro
culturing of ES cells (Enver et al. 2005; Shen et al. 2008; Bao et al. 2009).
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ES cell research continues to face obstacles for clinical applications because of a
wide range of variability in the maintenance of homogeneous and undifferentiated ES
cells over time during culture passages (Toyooka et al. 2008; Ying et al. 2008).
Furthermore, the signals or initial steps that originate deregulation of developmental gene
expression and epigenetic changes still remain unknown. Transcription factors and the
genetic network for pluripotency of ES cells have been widely described. POU class 5
homeobox 1(POU5F1, also known as OCT4), SRY-box containing gene 2 (SOX2), and
Nanog homeobox (NANOG) are three key master transcription factors that have been
identified and are responsible for the regulation and maintenance of pluripotency in ES
cells. They regulate themselves through positive feedback expression and are responsible
for the downstream transcriptional regulatory signals of more than 2,000 genes related to
pluripotency, self-renewal, surveillance, and cell lineage commitment (Boyer et al. 2005;
Loh et al. 2006; Chen et al. 2008).
ES cells that differentiate lose their pluripotency status and gain the lineagespecific signature via expression of their cell/tissue identity through gene and chromatin
modifications in the promoter regions of developmental genes responsible for
pluripotency and early cell differentiation (Mohn et al. 2008). Differentiation results from
alterations in ES cell pluripotency and self-renewal. Maintenance of a differentiated state
is a constant process of gene repression and/or activation coupled with chromatin
modifications that modulate specific signals that induce morphological and functional
characteristics in early cell progenitor derivatives during embryonic development (Niwa
et al. 2005). These genetic and epigenetic modifications guarantee expression of genes
involved in cell fate lineage and inactivation of developmental genes involved in
pluripotency. Covalent histone acetylation and methylation, chromatin remodeling,
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nucleosome assembly, and DNA methylation are all examples of epigenetic
modifications that result in packaging DNA. Developmental gene sequences become
inactivated; leading to their complete repression, avoidance of transcriptional protein
complexes formations, and certification that cell/tissue specificity (differentiated state)
would be maintained. Cell differentiation and tumor transformation both share several
molecular signaling pathways, including gene expression and epigenetic modifications
(Karakosta et al. 2005; Proia et al. 2011). Tumor cells display losses in genome integrity
due to accumulation of DNA damage induced by oxidative stress (Fearon and Vogelstein
1990). Unrepaired instability in single tandem repeat sequences can induce frame-shift
mutations in coding and non-coding regions of DNA, leading to failure in cellular
regulatory pathways such as cell cycle control, apoptosis, and DNA repair which are
needed in order to avoid cell transformation and maintain a differentiated state (Imai et
al. 2008).
When developmental genes are deregulated during neoplastic transformation, it
leads to cellular responses such as proliferation, de-differentiation, migration, invasion,
and angiogenesis, which ensure and ideal environment for tumor transformation (Gupta
et al. 2005; Ince et al. 2007). For example, aggressiveness and invasiveness are
fundamental characteristics of ovarian and breast tumor progression. Several authors
suggest that the ability of these cells to rapidly metastasize to different organs is due to
cell signals that trigger reactivation of developmental genes containing genomic
instability that may have originated during embryonic development; environmental
“triggers” could deregulate these genes, acting as an on-switch for cell tumor
transformation (Gupta et al. 2005). Genomic instability does not have to occur within a
gene to affect its expression. Instability could occur in flanking regions of developmental
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genes that are regulatory elements located upstream of promoters such as enhancer or
repressor sequences that modulate transcription factor binding. Several studies reported
the presence of regulatory elements localized in neighboring genes as enhancer or
repressor sequences determined to be responsible for transcription modulation (Lettice et
al. 2003; Kleinjan et al. 2006; Panne et al. 2007; Visel et al. 2009). Regulatory elements
are located upstream or downstream of transcription start sites. Some authors report that
they are within a 5 kb distance and others report distances up until 1 Mb (Lettice et al.
2003; Kleinjan et al. 2006; Visel et al. 2009). Several regulatory elements, or enhancers,
are binding sites of specific gene regulatory protein complexes that define and allow for
the sequential, specific development of embryos. Genetic control systems are established
early in development and cell fate is determined; cell memory mechanisms maintain
cellular specialization by remembering the early signals introduced during embryonic
development (Alberts et al. 2008).
We hypothesized that genomic instability in repetitive DNA sequences upstream
or downstream of specific genes could be a signal that regulates their expression; our
interest is in genes responsible for pluripotency, self-renewal, differentiation, or tumor
transformation. This instability could lead to activation or repression of transcriptional
regulatory elements in either normal ES cells or cancerous cells. Our objectives to test
this hypothesis were to:
1) Identify single tandem repeat sequences located near promoters of
developmental regulatory genes transcribed by the OCT4, NANOG, and
SOX2 transcription factors responsible for pluripotency and self-renewal of
ES cells,
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2) standardize use of primers to detect single tandem repeats in single genome
equivalent PCR amplifications via fragment analysis techniques to allow
determination of the mean frequencies of instability present per marker,
3) determine the accumulation of instability in these single tandem repeats
during ES cell culture of H1 and H7 ES cell lines by comparing mean
frequencies of instability at three cell passage ages,
4) identify pluripotency genes located near significantly unstable single tandem
repeats that could possibly be responsible for ES cell adaptation in vitro,
5) determine the accumulation of instability in single tandem repeats during ES
cell differentiation into embryoid bodies (EBs) by comparing mean
frequencies of instability in H1 and H7 ES cell lines at three different times
post EB initiation,
6) identify differentiation and chromatin assembly genes located near
significantly unstable single tandem repeats that could possibly be responsible
for ES cell differentiation in vitro,
7) expression pattern of genes located near unstable single tandem repeats in
cancerous ovarian cells in comparison with normal ovarian cells after 9 days
post-H2O2 exposure,
8) determine and describe possible instability signals (transcriptional regulators)
of gene expression in pluripotency, differentiation, chromatin assembly and
imprinting genes during ES cell culture and cell differentiation in vitro or
during cell transformation in ovarian cancer initiation and progression,
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9) contribute to the identification of possible biomarkers that could be useful for
screening and determining the quality of ES cells to be used for regenerative
therapies,
10) and identify possible biomarkers that could be used as diagnostic or
prognostic tests during cell transformation, progression, metastasis, or
treatment of tumors.
1.1
1.1.1

Review of pertinent literature
Embryogenesis and embryonic stem cell origins
During mammalian ovulation and fertilization, once an oocyte is in the fallopian

tube, it oocyte completes metaphase II after extrusion of the first polar body. Once
fertilized with sperm the oocyte is activated, and the second polar body is then extruded.
Immediately, sperm DNA remodeling is initiated and takes approximately 6-8 hours.
This includes decondensation of sperm chromosomes, giving rise to the first pronucleus
(male pronucleus), and also decondensation of oocyte chromosomes giving rise to the
second pronucleus (female pronucleus). The pronuclei are haploid, each containing one
set of chromosomes (Kiessling and Anderson 2007; Alberts et al. 2008). DNA synthesis
is then initiated independently in both pronuclei. Next, pronuclei fusion occurs and the
zygote is ready for the first cleavage which is an equal division into two daughter cells,
each containing a diploid set of chromosomes; this occurs approximately 22 to 26 hours
after fertilization (Braude et al. 1988; Alberts et al. 2008) (Figure 1.1).
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Figure 1.1

Diagram of human embryonic development.

Notes: (A) In vivo human embryonic development, starting with fertilization on day zero,
goes through serial cleavages that occur starting at the two cell embryo stage at 2 days
post-fertilization, until more than 200 cells are present in the morula stage at day 4. On
day 7 post-fertilization, the first embryonic commitment signal for transformation into a
blastocyst occurs. An external layer of trophoblast is differentiated and surrounds the
ICM that will gives rise to the three germinal layers after implantation of the blastocyst
(B) In vitro isolation of ES cell lines from the ICM of the blastocyst lead to the posterior
differentiation of embryoid bodies, resulting in the generation of the three germinal
layers.
These two daughter cells are known as a blastomere which is totipotent, a status
defined by the capacity to derive a complete individual (placenta, extraembryonic
membranes, and embryo). The second cleavage of the two cell blastomere results in four
cells, and each successive cleavage results in the doubling of blastomere cells. At the fifth
cleavage of 16 cells into 32 cells 3 days after fertilization, the blastomere is now at the
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morula stage. (Braude et al. 1988; Kiessling and Anderson 2007; Alberts et al. 2008). At
this stage, there is induction of the first embryonic commitment signal that transforms
into a blastocyst, composed of an external layer of trophoblast that gives rise to the
placenta and an internal group of cells called the inner cell mass (ICM). The ICM is what
gives rise to the embryo (Kiessling and Anderson 2007; Alberts et al. 2008). ICM cells
are pluripotent, meaning they can differentiate into any cell type from the three
embryonic layers, but cannot become placental tissue (Thomson et al. 1998; Reubinoff et
al. 2000). At this stage, the blastocyst arrives in the uterus, where the ICM has a second
differentiation event, taking on a flat appearance and giving rise to the primitive
endoderm. The primitive endoderm creates the extra embryonic membranes, including
the amniotic sac that contains the fetus during development (Enders and King 1988).
Interaction of the blastocyst with the endometrium starts implantation on the day
after fertilization; the trophoblast invades uterine epithelium and placenta formation
begins (Georgiades et al. 2002). After implantation, the bulk of the embryonic stem cells
begin undergoing differentiation events that commit them into the three germinal layers,
the outer germ layer, and ectoderm, is the precursor for the epidermis and the nervous
system. The inner germ layer, endoderm, is the precursor for the gut, lung, and liver. The
middle germ layer, mesoderm between ectoderm and endoderm, is the precursor for
muscle and other connective tissues (Pelton et al. 2002; Kiessling and Anderson 2007;
Alberts et al. 2008).
In research, in vitro techniques have been used to develop embryos up until the
blastocyst stage when the ICM can be isolated and maintained as an embryonic stem cell
line in culture that preserves pluripotency and self-renewal features across passages
(Thomson et al. 1998). Additionally, this preserves the ability in vitro to differentiate into
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embryoid bodies (EBs) of any cell type from the three embryonic layers (mesoderm,
ectoderm and endoderm) (Itskovitz-Eldor et al. 2000). When ES cells are injected into a
mouse with immune suppression, the ES cells have the capacity to form teratomas in
vivo. These teratomas can contain structures that resemble gut epithelium (endoderm
layer), smooth and striated muscle (mesoderm layer), and neural epithelium (ectoderm
layer) (Caricasole et al. 1998).
ES cells are classified into the following three categories according to their level
of potency and plasticity: (1) totipotent cells have a capacity to give rise to an entire
organism (e.g. blastomere), (2) pluripotent cells have the ability to give rise to the three
embryonic layers but cannot develop extra embryonic tissue and a fetus (e.g. ICM/ES
cells), and (3) multipotent cells have the ability differentiate into mature somatic cells for
a specific tissue and have lost the ability to differentiate into any other tissue type (e.g.
hematopoietic stem cells that differentiate in red and white blood cells and platelets).
Currently, in vitro, human ES cells have been differentiated into neuroectoderm
(Carpenter et al. 2001; Schulz et al. 2003; Ben-Hur et al. 2004), hematopoietic
progenitors (Chadwick et al. 2003), endothelial cells (Gerecht-Nir et al. 2003),
osteoblasts (Sottile et al. 2003), cardiac muscle (Kehat et al. 2001; Mummery et al. 2003;
Mazhari and Hare 2007; Yang et al. 2008), pancreatic β cells (Assady et al. 2001; Burke
et al. 2007), hepatic cells (Rambhatla et al. 2003), and skin cells (Green et al. 2003). ES
cells differentiation into functional cell fate lineages of pancreas, heart, and neural
systems are under constant scientific research.
ES cell embryologic development research has evolved for different tissue types
to determine and validate of possible tissue engineering techniques for potential clinical
applications. For example, the pancreas is an organ that plays an important role in
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glucagon production which is essential for glucose regulation. Diabetes type I is caused
by the disruption of pancreatic β cells in the langerhans islets, allowing deregulation of
glucose levels (Burke et al. 2007). Diabetes is treated by exogenous insulin injections.
However, pancreatic cell transplantation can offer a better permanent solution, but
insufficient numbers of compatible cells prevent this from being a successful therapeutic
approach (Korsgren et al. 2005). Instead, ES cells differentiated and derived into the
pancreatic cell lineage could be a solution for this disease that affects approximately 5
million people worldwide (Lu et al. 2007). Myocardial infarction is another example
where ES cells could be derived into cardiac muscle cells as a treatment to replace
damaged cardiac tissue, and in patients with potential heart failure; use of ES cell
transplants as a source of cardiac cell remodeling could be part of cardio protective
therapy (Mazhari and Hare 2007; Mazhari and Hare 2007; Yang et al. 2008). A final
example is use in traumatic spinal cord injury that usually results in irreversible damage
and disability. Transplanting ES cells derived into neuroprogenitors could be a solution
for regenerating and repairing this damage, and, after supportive physical therapy, could
offer recovery from that disability (Ben-Hur et al. 2004).
ES cell studies continue to evolve with the development of better protocols to
direct differentiation and ensure genomic stability of specific, functional cell lineages
derivatives to be used in cell transplantation and tissue regeneration applications.
1.1.2

Pluripotency and self-renewal of embryonic stem cells
As mentioned, pluripotency of early embryonic stem cells is maintained through

key transcription factors, including OCT4, NANOG, and SOX2. These are considered to
be the three master regulatory genes that control pathways of pluripotency, self-renewal,
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surveillance, and cell lineage determination (Loh et al. 2006). They function as
transcription factors that bind downstream target sequences of pluripotent genes,
including fibroblast growth factor-4 (FGF4), undifferentiated embryonic cell
transcription factor 1(UTF1), F-box protein 15 (FBXO15), and left-right determination
factor 1 (LEFTY1) (Vallier et al. 2005). OCT4, NANOG, and SOX2 regulate their
expression directly via positive feedback loops. Several reports have established that
OCT4, NANOG, and SOX2 are the main transcription factors responsible for progression
of early embryonic development in vivo and ES cell maintenance in vitro (Abeyta et al.
2004; Boyer et al. 2005; Babaie et al. 2007; Masui et al. 2007). Recently, Yu & Thomson
et al. 2007 and Takahashi et al. 2006 have demonstrated that these three master genes
work together in concert with two additional transcription factors, namely c-myc and
Klf4, to reprogram adult cells into induced pluripotent stem cells (iPS) from both
embryonic and adult fibroblasts. Although it is known that both c-myc and Klf4 function
either directly or indirectly as oncogenes, their roles in early embryonic development in
vivo relative to OCT4, NANOG, and SOX2 are less defined.
The OCT4, NANOG, and SOX2 transcription factors are expressed in
undifferentiated ES cells (Boyer et al. 2005; Lee et al. 2006; Creyghton et al. 2010).
Experiments which use interference RNA (RNAi) to selectively turn off each one of
these genes, one or two at a time, provide clues as to their function during early
embryonic development. For example, when both OCT4 and NANOG are silenced, cells
lose their pluripotency and show inappropriate differentiation to inner cell mass,
trophectoderm, and extra embryonic endoderm (Chambers et al. 2003; Alon 2007; Hu et
al. 2009). The promoter region of 623 genes contains the target sequence (ATGCAAAT)
for OCT4, 1,271 genes contain target sequences for NANOG and 1,687 genes contain
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target sequences for SOX2. Also, OCT4, NANOG, and SOX2 are co-involved and
overlap in promoter regions of at least 353 coding genes (Boyer et al. 2005; Chia et al.
2010; Fernandez-Tresguerres et al. 2010).
1.1.3

Differentiation of embryonic stem cells
Essential cellular processes ensure correct body formation during early embryonic

development. First, cells proliferate by embryonic cleavage stages. All cells in the body
originate from one cell (egg after fertilization). Second, cell specialization from the ICM
to all the cells in the body is produced with their specific features. Third, cell interactions
coordinate signals between cells and the surrounding environment. Fourth, cell migration
causes cell assembly during embryonic development into tissues and organs (Alberts et
al. 2008).
Functional genomics studies aimed at identifying key regulatory genes involved
in the initiation of differentiation events have shown that LIF, bone morphogenesis
protein 4 (BMP4), wingless-type MMTV interaction site family (WNT), and Fibroblast
growth factor- beta (FGF-β) are all factors that play important roles in differentiation
signaling pathways (Niwa et al. 1998; Ying et al. 2003; Goldstein et al. 2005). Initially,
ES cells were isolated and maintained on mouse feeder layers that supplied critical
growth factors for ES cell survival. Individual growth and inhibitory factors have been
identified from these early experiments and have led to the discovery that ES cells can be
maintained without feeder layers if the cultures are supplemented with LIF. When
cultured ES cells are deprived of LIF, differentiation to primitive ectoderm occurs (Chen
et al. 2008). Therefore, LIF has the ability to maintain ES cells in a stable pluripotent
state in vitro. Also, the differentiation into skin and neural ectoderm is mediated by
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BMP4 and WNT, respectively (Goldstein et al. 2005). BMP4 is also a regulator of germ
cell development in the mouse embryo (Lawson et al. 1999) and acts to inhibit neuroectoderm development while allowing differentiation to mesoderm (Ying et al. 2003).
WNT is a secretory protein that controls the cell cycle during mouse and human
embryogenesis. The WNT pathway is activated during ES cell culturing in absence of
MEF and retains undifferentiated characteristics for short periods of time (5-7 days).
During embryoid body formation, WNT inhibits the secreted frizzled-related protein 2
(SFRP2) signal and leads to neural development (Sato et al. 2004).
1.1.4

Genomic instability in embryonic stem cells
DNA genomic instability is an accumulative process that leads to gene expression

deregulation as a mechanism of ES cell culture adaptation in vitro or tumor
transformation in vivo. Genomic instability is originated by different changes on single
tandem repeat sequences, accumulation of point mutations, deletions, insertions, nonsense mutations, and numerical and structural rearrangements in the chromosomes (Niwa
2006; Imai et al. 2008; Martinez and Kolodner 2010). Genomic instability can lead to the
disruption of gene expression network modulators that govern cell survival and growth
advantages favoring adaptation during in vitro culturing (Niwa 2006).
Chromosomal instability (CI) displays disruption of DNA replication, telomere
maintenance, DNA repair, chromosome condensation, sister chromatid cohesion, and cell
cycles (Wang et al. 2004; Weaver and Cleveland 2007; Barber et al. 2008). Unrepaired
genetic alterations have been shown to lead to oncogenesis, and these genetic changes
mainly affect self-renewal, cell differentiation, apoptosis, and cell cycles, resulting in
uncontrolled increases of cell growth. In this way, ES cells have a growth advantage in
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vitro (Brimble et al. 2004; Maitra et al. 2005; Olariu et al. 2010). Karyotype
abnormalities determined by cytogenetic analysis, comparative genomic hybridization
(CGH), or single nucleotide polymorphisms (SNP) have been reported by many ES cells
laboratories (Draper et al. 2004; Inzunza et al. 2004; Maitra et al. 2005; Mitalipova et al.
2005).
Initially, the most frequent karyotype alterations showed in ES cells in vitro is
gains of chromosomes 12 [isochromosome 12p (i12p)], 17q and X (Summersgill et al.
2001). Trisomies in chromosomes 1, 2, 3, 7, 8, 9, 11, 13, 14, 18, and 20 have also been
reported but at a lower frequency (Draper et al. 2004; Inzunza et al. 2004; Maitra et al.
2005; Mitalipova et al. 2005). These abnormalities have been observed during the
oncogenesis process for tumors such as testicular germ cell tumors, seminomas, and
choriocarcinomas (Abeyta et al. 2004; Mitalipova et al. 2005). Similar to tumor cells, the
unstable chromosomes of ES cells carry genes involved with cell growth, self-renewal,
and pluripotency. It is well established that CI occurs during later passages as a signal of
adaptation in ES cells in vitro (Maitra et al. 2005; Mitalipova et al. 2005).
Interestingly, CI occurs in the key pluripotent gene NANOG that is located in
chromosome 12p13.31 (Lindgren et al. 2011). Overexpression of this gene has been
observed to promote self-renewal, prevent differentiation, and give advantages to the in
vitro adaptation mechanism (Chambers et al. 2003). Other associated gene such as the
developmental pluripotency associated 3 (DPPA3 also known as STELLA) gene located
in the 12p13.31 region, codes for a protein that functions as a transcriptional repressor
and is in charge of maintaining cell pluripotency (Nakamura et al. 2007). The growth
differentiation factor 3(GDF3) gene, located in the 12p13.1 region, is a member of the
bone morphogenetic protein (BMP) family and the transforming growth factor-beta
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(TGF-β) superfamily that regulates cell growth and differentiation during embryogenesis
(Levine and Brivanlou 2006). The Cyclin-D2 (CCND2) gene, located in 12p13 region, is
a regulator of CDK kinases that regulate cell cycle G1/S transitions (Mai et al. 1999).
Indeed, the 12p12.1 region has been reported to be a critical region for mutations and
instability because it contains the oncogene vi-ki-ras 2 kirsten rat sarcoma viral oncogen
homolog (KRAS) that is involved in tumorigenesis (Tol et al. 2010) and the SRY sex
determining region Y-box5 (SOX5) gene which is responsible for determination of cell
fate during embryogenesis (Martinez-Morales et al. 2010).
Another unstable chromosome found in ES cells lines is chromosome 17. Several
groups have reported that ES cells tend to gain material from chromosome region 17q
(17q21 and 17q23.2) (Thomson et al. 1998; Azuhata et al. 2001; Draper et al. 2004;
Maitra et al. 2005; Mitalipova et al. 2005). Interestingly, the antiapoptotic gene
baculoviral IAP repeat containing 5 (BIRC5) is located in this region. Also, genes
abnormally up-regulated in ES cell lines with 17p11.2 aberrations are the topoisomerase
DNA III alpha (TOP3A) gene located in the 17p12 region, mitogen-activated protein
kinase 7 (MAPK7), and growth factor receptor bound protein 2 (GRB2) are both located
in 17q24 region. These three genes are responsible for maintaining cells in an
undifferentiated state and reducing apoptotic signals through transcription regulation
during proliferation, differentiation, and embryonic development (Azuhata et al. 2001;
Blagoev et al. 2003; Temime-Smaali et al. 2008; Rousseau et al. 2010).
Another chromosome that shows instability in some ES cell lines is the X
chromosome which has been shown to have multiple copies (Thomson et al. 1998;
Sperger et al. 2003). Gains of an X chromosome can cause failure of X inactivation when
the X (inactive)-specific transcript (XIST) gene is not expressed (Sperger et al. 2003).
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Some female ES cell lines do not express the XIST gene and their undifferentiated
progeny shows active X chromosomes. It appears as though X inactivation occurs
through differentiation progression (Dhara and Benvenisty 2004). Oncogenes, such as
members of the ETS (ELK1) oncogene family located in the Xp11.2 region and v-raf
murine sarcoma 3611 viral oncogene homolog (ARAF) located in the Xp11.4 region, are
cell signaling molecules present in X chromosomes and may be involved in cell growth
and development (Wu et al. 1996; Yang et al. 2003; Allegrucci et al. 2007).
1.1.5

Epigenetic instability in embryonic stem cells
Epigenetic factors regulate gene expression without changing DNA sequences.

Promoter methylation or chromatin assembly modifications are responsible for this
modulation of gene expression during pluripotency and cell lineage commitment early
during embryonic development. ES cell lines carry inherent differences in gene
expression and epigenetic modifications, including changes in the DNA methylation
patterns of genes required for pluripotency, self-renewal, and differentiation (Allegrucci
et al. 2007). Under appropriate differentiation conditions, ES cells have the potential to
become any and all cell types in the human body (Shiota et al. 2002; Jaenisch and Bird
2003). Transcriptome deregulation, DNA methylation losses or gains, histone acetylation,
and chromatin remodeling modifications can be acquired over time in ES cell in vitro
cultures and are examples of epigenetic alterations (Jaenisch and Bird 2003). Epigenetic
deregulation leads to reactivation of imprinted genes that lead to a loss of pluripotency
and promotes cell differentiation or cell transformation.
DNA methylation is an epigenetic modification that regulates gene expression
during cell proliferation, differentiation, imprinting, nucleosome remodeling, and X
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chromosome inactivation. OCT4, SOX2, and NANOG are unmethylated in ES cells and
become repressed by de novo DNA methylation as a signal of lineage commitment
during early cell differentiation. The methylation patterns are maintained across the
subsequent cell divisions, ensuring the epigenome cellular program of that specific
lineage commitment (Ahmed et al. 2010). Promotor hypermethylation of genes
responsible for embryonic development and cell differentiation are a crucial epigenetic
modification for ES cell maintenance in vitro (Allegrucci et al. 2007). This silencing of
developmental genes is maintained between subsequent cell cycles (Jaenisch and Bird
2003). In addition, the regulation of gene expression can be mediated by methylation of
promoter regions associated with CpG islands which are also referred to as differentially
methylated regions (DMRs). Usually, these DMRs are tissue specific (Shiota et al.
2002). The culture environment induces chromosomal and genomic instability in DNA
methylation patterns and confers adaptation of ES cells in vitro to maintain an
undifferentiated state over extended periods of time through methylation changes at
sensitive loci. In contrast, DNA hypomethylation is frequently seen in ES cells during in
vitro expansion and in vivo cancer transformation. Establishment and maintenance of
DNA methylation is important in ES cell development, expansion, and genomic stability
(Kim et al. 2004).
Effects of genomic instability and DNA methylation on mutation rates are now an
important research focus for improving the culture environment of ES cells intended for
therapeutic uses. Changes in the DNA methylation of gene promoters in undifferentiated
cell during long-term in vitro expansion have been observed for imprinted genes such as
insulin like growth factor 2 (somatomedin A) (IGF2) involved in embryonic
development, and X-inactivated specific transcript (XIST) in charge of X inactivation
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(Allegrucci et al. 2007). ES cell lines are characterized by a set of criteria that change
during cell line development and differentiation. These criteria include differences in
gene expression and can be observed in alterations of allelic expression in imprinted
genes such as XIST, which is a crucial gene for X-inactivation (Adewumi et al. 2007;
Shen et al. 2008).
In vitro culture of ES cells contributes to changes in CpG methylation patterns
and genomic instability in different cell lines established over the years (Tomkins et al.
2002). The initiation and maintenance of XIST is extremely important for embryogenesis
and adult cell physiology (Shen et al. 2008). Demethylation of XIST promoter CpG
islands have been related to increased levels of gene expression of X-linked genes such as
plastin 3 isoform 1 (PLS3) located in the Xq23 region, retinoblastoma binding protein 7
(RBBP7) located in the Xp22.2 region, and SWI/SNF related matrix associated and actin
regulator of chromatin subfamily A member 1 (SMARCA1) located in the Xq25 region
which are responsible for chromatin remodeling (Ye et al. 2009; Wirt et al. 2010). ES
cell databases showing differentiation-associated gene expression revealed that ES cell
lines exhibit patterns of loss of methylation in genes that are normally up-regulated
during cellular differentiation. These changes in methylation are also similar to those that
occur during tumorigenesis (Smiraglia and Plass 2002; Baker et al. 2007). In comparison
to cell transformation during tumorigenesis, hypomethylation can induce microsatellite
instability and chromosomal instability (Eden et al. 2003). DNMT1 and MLH1 have
binding sites for several genes involved in DNA replication (Umar et al. 1996; Guo et al.
2004; Athanasiadou et al. 2010; Sen et al. 2010). It has been reported that human MLH1
is silenced by a hypermethylated pattern in its promoter CpG islands in about 15-20% of
colorectal cancers that exhibit MSI (Imai et al. 2008). This association of DNMT1 and
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MLH1 in the same pathway of genomic instability confirms that down-regulation of gene
expression is due to changes in the epigenetic patterns of DNA methylation (Lengauer et
al. 1997; Guo et al. 2004).
1.1.6

Applications of embryonic stem cell
More than 100 companies in 300 countries are interested in regenerative medical

applications of ES cells (Parson 2008). Improvements in the standardized protocols for
ES cell in vitro culture maintenance, isolation in xeno-free conditions, specific
differentiation in all different cell lineages of the body, and large scale production can
only continue depending on the scientific discoveries detailing the specifications to which
ES cells can be safely used in clinical applications (Holm et al. 2010). Complete and
constant interaction is needed between scientists and clinicians for the selection of
appropriate patients that could be candidates for ES cell transplants. Although ES cells
are the source of restoring tissue function, they need the best available tissue environment
to guarantee their complete in vivo stability and functionality.
Clinical studies have evaluated and validated protocols to direct cell lineage
specificity into one of three different embryonic layers. An example is the potential use
of ES cells for pancreatic tissue development. Researchers studied gene pattern and
transcription factors involved in pancreatic differentiation and the determination of
activin and fibroblast growth factor-2 (FGF2) that mediated pancreatic development in
vitro (Burke et al. 2007). One goal is to drive these pancreatic cells into specific β-cells
for insulin production (Dor et al. 2004; D'Amour et al. 2006). Another example is the
potential use of ES cells for cardiac tissue regeneration; embryoid bodies show
contractile cardiac muscle characteristics and are troponin positive. Experimentation in
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rats has shown improvement of cardiac function after ES cell transplant (Min et al. 2003;
Zhou et al. 2008). Yet another example is the potential use of ES cells to regenerate
neural tissue. This has been studied in primate ES cell lines differentiated into
dopamanergic cells for treatment of a primate Parkinson disease model (Ben-Hur et al.
2004). In mice, transplantion of oligodendrocyte progenitors increased myelination and
locomotion (Keirstead et al. 2005). These are a few examples of the successes in
transplanting ES cells for use as a source of cells in tissue regeneration for different
pathologic approaches.
1.1.7

Cell transformation and tumorigenesis signaling
Cell transformation signals are similar to signals for cell specialization during

early embryonic development. Several studies have reported that tumor cells expressed
pluripotency genes allowed cell proliferation and tumor formation (Ince et al. 2007;
Ratajczak et al. 2010; Lindgren et al. 2011). Cancer cells have been shown to have both
genomic instability and hypermethylation of DNA repair and tumor suppressor
mechanisms, aiding tumor initiation and progression. Evans, et al, reported the
similarities of morphological characteristics between embryo carcinoma colonies and the
blastocyst inner cell mass which are known for their variety of undifferentiated stem cells
and differentiated cells from the three germinal layers (Evans and Kaufman 1981).
In normal cells, methylation patterns are maintained across cell divisions, only
allowing gene expression of tissue-specific genes necessary for cellular functions. Cancer
is induced by disruption of these methylation patterns established during differentiation
or during de novo methylation early in embryonic development (Calvanese et al. 2008).
Deregulation through hypermethylation of tumor suppressor genes during tumor
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transformation have been reported in p53, BRCA1, RB1, INK4, APC, PTEN, and p21
(Melki et al. 1999) and hypomethylation of oncogenes such as RAS, BCR/ABL, CCND1,
ERG1, MYC, EGFR, and FOS. Mutation noted in KRAS and p53 are examples of those
originated by oxidative stress damage to the cells leading to missense mutations common
in different cancer types such as glioma, liver, and bladder cancer (Rauch et al. 2008).
Deregulated MMR mechanisms have also been induced by genomic instability that
allows accumulation of mutations leading to tumor transformation (Rodríguez-Jiménez et
al. 2008) ensuring cell proliferation and avoiding apoptosis signals.
The environment can affect genomic integrity and induce epigenetic changes
responsible for losses in repressive chromatin in developmental genes. These genes can
then become active and lead the cell to oncogenic transformation, contributing to
expansion and migration of tumor cells in the body. Developmental genes showed
particular histone patterns that ensure gene silencing in specialized tissue. However,
modifications in histone during differentiation lineage commitment are responsible for
mutations in somatic cells. These tumor stem cells then initiate tumor transformation
(Gupta et al. 2005; Ince et al. 2007; Imai et al. 2008).
1.2

Significance of the research
Understanding critical pathways of pluripotency, self-renewal, and differentiation

during early development is important for the evaluation of the therapeutic potential of
ES cells because of their potential for tumor transformation due to genetic and epigenetic
instability acquired during in vitro culture maintenance. ES cells are a perfect model in
developmental biology studies due to their potential to differentiate in vitro. Cultured ES
cells and embryoid bodies can be used as a model for determination of the earliest
22

embryonic developmental pathways of pluripotency and self-renewal that lead to cell
lineage commitment in vitro. Refinement of culture systems will allow the differentiation
of specific lineages that are a source of all types of cells for regenerative medicine. They
provide an ideal population of lineage-specific cells that can be used as a model system to
measure toxicity and pharmaceutical drug safety. Genetically modified ES cells with
specific genotypes provide a model for understanding mechanisms of disease initiation,
progression, and treatment. Determining genetic and epigenetic modifications, including
single tandem repeat instability, gene expression changes, and chromatin modifications,
are essential for determining potential biomarkers for diagnostic purposes that ensure ES
cell stability and integrity needed for regenerative medicine.
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CHAPTER II
DEVELOPMENT OF SINGLE TANDEM REPEAT SEQUENCE MULTIPLEXES
FOR HUMAN EMBRYONIC STEM CELL EVALUATIONS OF GENOMIC
AND EPIGENOMIC INTEGRITY DURING IN VITRO CULTURE
2.1

Abstract
Twenty multiplexes with 64 single tandem repeat markers were standardized to

determine genomic instability involved in cell differentiation of ES cells and cell
transformation in ovarian tumor progression. These multiplexes included markers located
near pluripotency, self-renewal, differentiation, and chromatin assembly genes. Each
multiplex showed simultaneous amplification of 3 to 5 markers labeled with FAM or
HEX fluorescent dyes. Standardization was performed in different conditions that
included primer design avoiding overlapping, PCR product size in range of 100 to 400
base pairs (bp), PCR buffer, MgCl2, primer, and Taq polymerase concentration.
Additionally, DMSO and BSA reagents were tested at different concentrations as
enhancers of the PCR and different steps on the amplification protocol were examined:
annealing temperature, final extension time, and number of amplification cycles. PCR
conditions optimized for evaluation of DNA integrity by detection of unstable repeat
markers at the single genome equivalent level (25-50 pg/µl) of DNA are presented. These
conditions ensure sensitivity to detect wild type and mutated alleles at their appropriate
frequency of in vitro samples during and after culture passages, cell differentiation of ES
cells, and cell transformation on ovarian tumor cells.
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2.2

Introduction
Single tandem repeats (STR) of 2-6 nucleotide units are polymorphic genetic

markers useful in multiple scientific areas such as disease predisposition, susceptibility,
diagnostics and prognostics, human identification for forensic cases or paternity probes,
population genetics, and gene mapping (Shuber et al. 1995; Jakupciak and Wells 1999;
Berg et al. 2000; Butler et al. 2001; Collins et al. 2003; Krenke et al. 2005). Accurate
standardization of genetic markers ensures the efficiency of diagnostic methods used in
human diseases such as cancer, neurodegenerative, or fragile sites in chromosome related
diseases.
STR multiplexing refers to simultaneous amplifications of many STRs in the
same PCR reaction. Several reports have been published about multiplexing STR
markers for forensic and cancer research (Berg et al. 2000; Butler et al. 2001; Mulero et
al. 2006). However, no reports that validate specific STR markers located in close
proximity to specific genes involved during embryonic development, differentiation,
chromatin assembly, and genomic imprinting pathways exit.
STRs may be potential biomarkers to determine genomic stability during human
embryonic developmental events. Instability detection in repetitive markers near these
genes could be a signal of pluripotency or differentiation of ES cell lines maintained in
vitro. Therefore, STR standardization methods are important for ES cell characterization
and validation for safe application in regenerative medicine. This protocol allows for the
selection and validation of specific STR markers in multiplex sets. Validation of STR
multiplexes is a novel tool for evaluation ES cell genome integrity during and after
culturing in long term in vitro passages.
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2.3
2.3.1

Methodology
DNA samples
Genomic DNA was isolated from blood samples donated for this research by

informed consent (IRB approval number 11-088) and ES cells H1-WA01 and H7-WA07
purchased from the National Stem Cell Bank – Wisconsin International Stem Cell Bank
(Appendix B) with the Purelink™ genomic DNA mini-kit (Invitrogen Carlsbad, CA)
following the manufacturer’s protocol. All DNA samples were quantified using a
NanoDrop™ ND1000 spectrophotometer (Thermo Scientific, Wilmington, DE).
Titrations of DNA were made at different concentrations from 500 pg/µl to 25 pg/µl.
High DNA concentrations were used for amplification of both wild type alleles and low
concentration (single genome equivalent DNA concentration) that allow detection of wild
type and mutated alleles with accurate frequency.
2.3.2

Selection of tandem repeat sequences
We located 312 tandem repeats containing repeat motifs (mono- , di-, tri-, tetra-,

penta-, and hexanucleotide repeats) located in or near promoter regions of specific genes
involved in pluripotency, self-renewal, differentiation, chromatin assembly, and
imprinting (Appendix A). To determine the presence of tandem repeat motifs near
promoter regions, we analyzed gene sequences 1000 bp upstream and downstream of the
promoter using the UCSC Genome Browser (http://genome.ucsc.edu/cgi-bin/) and the
NCBI database (http://www.ncbi.nlm.nih.gov/genome/sts/sts.cgi). A total of 3,489 target
genes involved in pluripotency and self-renewal were analyzed: 623 genes transcribed by
OCT4 transcription factor, 1,587 genes transcribed by NANOG transcription factor,
1,279 genes transcribed by SOX2 transcription factor, and 353 genes transcribed by
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OCT4, NANOG and SOX2 transcription factor. The target genes of OCT4, NANOG and
SOX2 transcription factor database are available at
www.wi.mit.edu/young/hESregulation/ (Boyer et al. 2005)
2.3.3
2.3.3.1

Primer design
Software designer
To select the ideal oligonucleotide to be standardized by high concentration DNA

(500 pg/µl) and low concen
concentration DNA (single cell DNA equivalent 50 pg/µl
pg/ or 25
pg/µl),
), primers were designed to amplify identified single tandem repeats in promoter
regions with oligo-perfect
perfect designer softwa
software
(http://tools.invitrogen.com/content.cfm?pageid=9716
p://tools.invitrogen.com/content.cfm?pageid=9716) (Invitrogen, Carlsbad, CA).
CA This
software facilitates the design of oligonucleotide primers when target sequences are in
FASTA format. These oligonucleotide sequences were validated in UCSC Genome
Browser (http://genome.ucsc.edu/cgi
http://genome.ucsc.edu/cgi-bin/)) to confirm the chromosomal location and
DNA sequence that contained the specific repeat sequence of interest.
2.3.3.2

Gene bank primer sequences
Other markers were identified in specific genes using the NCBI database

(http://www.ncbi.nlm.nih.gov/unists/).
http://www.ncbi.nlm.nih.gov/unists/). The respective primer sequences identified in this
database were validated using the UCSC Genome Browser. In Appendix A, 312
identified tandem repeat motifs located in promoter pproximal regions of important
pluripotency, self-renewal,
renewal, differentiation, chromatin assembly, and imprinting genes are
summarized.
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2.3.4

Singleplex PCR optimization
Before standardization of primers, we collected the STR marker’s reference allele

size, motif, and primer concentration reported in NCBI database and previous public
reports. We used BLAST with the designed primers to check for potentially negative
primer interactions. Fluorescent primers were purchased from IDT (Coralville, IA) at 100
µM. The labeled dyes used were 6-FAM (blue), HEX (green), and NED (yellow). For
initial testing, forward and reverse primers were combined at a final concentration of 25
µM each to create a singleplex primer stock.
Each STR primer pair was optimized to obtain amplified products with robust
signal intensity and balanced peak heights from DNA samples in three concentrations
500, 100, and 50 pg/µl. Each locus was standardized in single PCR reactions to optimize
the primer balance (concentration), specificity, and sensitivity of each amplified signal
from each STR. The final concentration of primers was tested with two concentrations
(0.8 and 1.5 µM). PCR amplification was carried out in a total reaction volume of 10 µl
that contained: 1X of buffer D (800 mM Tris HCL, 200 mM (NH4)2SO4, 0.2% w/v
Tween 20) (US DNA, Fort Worth, TX), 2.5 mM of MgCl2 (US DNA, Fort Worth, TX),
1.25 U of Hot-MultiTaq DNA polymerase (US DNA, Fort Worth, TX), 300 µM of
dNTPs mix (Applied Biosystems, Foster City, CA). PCR was performed on a PE 9600
thermocycler (Perkin Elmer, Waltham, MA) using the following protocol: 1 cycle of
95°C for 11 minutes; 30 cycles (ramp 4 minutes to 94°C, hold for 10 seconds and ramp 50
seconds to 70°C, hold for 60 seconds); then, final extension of 60°C for 30 minutes, and
hold at 4°C. Negative controls were included for each run to check for contamination and
dye artifacts.
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2.3.5

Multiplex PCR Optimization
After optimizing all STR markers with single marker PCR reactions, we began

selection for multiplexing primers based on allele base pair (bp) size. The markers set per
multiplex were organized between ranges of 100-400 bp. Determined space between
markers was estimated, which is dependent upon the number of bases in the repeat motif
(Idury and Cardon 1997). For example, shorter distances are needed between
mononucleotides and dinucleotides, and larger distances are needed between tri-, tetra-,
or pentanucleotides markers. Primers were multiplexed together according to similarities
in primer concentration, repeat motifs (mononucleotides with mononucleotides,
dinucleotides with dinucleotides, etc), and primers with the same fluorescent label (6FAM, HEX, or NED). Two different concentrations of DNA were used, 100 pg/µl and 50
pg/ul, and the final concentration of primers that was determined for singleplex PCR. We
tested different conditions and concentrations for PCR to ensure co-amplification of the
primers in each multiplex designed. The following different PCR components and
concentrations were tested: standard buffer with 800 mM Tris HCL, 200 mM (NH4)2SO4,
and 0.2% w/v Tween 20 (US DNA, Fort Worth, TX), two concentrations of MgCl2 (2.0
and 2.5 mM) (US DNA, Fort Worth, TX), and three concentrations of Hot-MultiTaq (1.5,
2.0, and 4.0 U) (US DNA, Fort Worth, TX). Each component was tested individually as a
series of titrations around a singleplex optimized condition. PCR was performed on a
PE 9600 thermocycler (Perkin Elmer, Waltham, MA) using the following protocol: 1
cycle of 95°C for 11 minutes; 30 cycles (ramp 4 minutes to 94°C, hold for 10 seconds and
ramp 50 seconds to 70°C, hold for 60 seconds); then, final extension of 60°C for 30
minutes, and hold at 4°C. Negative controls were included for each run to check for
contamination and dye artifacts.
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2.3.6

PCR enhancers
Amplification sensitivity was test with PCR enhancers by using two

concentrations of dimethylsulfoxide (DMSO) (2 and 4%) and bovine serum albumin
(BSA) (0.2 and 0.4 mg/µl). DMSO decreases hydrogen bond formation between DNA
strands, and BSA helps stabilize and enhance DNA polymerase activity during PCR
amplification (Sahdev et al. 2007; Eilert and Foran 2009) (Figure 2.1).
2.3.7

Final PCR standardized conditions
PCR amplifications were performed in a total reaction volume of 10 µl containing

1X of buffer D (800 mM Tris HCL, 200 mM (NH4)2SO4, and 0.2% w/v Tween 20) (US
DNA, Fort Worth, TX), 2.5 mM of MgCl2 (US DNA, Fort Worth, TX), 1.25 U of HotMultiTaq DNA polymerase (US DNA, Fort Worth, TX), 4% of DMSO (Sigma Aldrich,
Saint Louis, MO), 0.4 mg/ml of BSA (Thermo Scientific, Rockford, IL), 300 µM of
dNTPs (Applied Biosystems, Foster City, CA), and 1X of Solution L (US DNA, Fort
Worth, TX). Primer concentration, sequences, genebank information, and dye label for
each of the 64 STR primers are shown on Table 2.1-2.2. PCR ramping protocol: 1 cycle
of 95°C for 11 minutes; 1 cycle of 96°C for 1 minute; 10 cycles of [94°C for 30 seconds,
ramp 68 seconds to 58°C (hold for 30 seconds), ramp 50 seconds to 70°C (hold for 60
seconds)]; 25 cycles of [90°C for 30 seconds, ramp 60 seconds to 58°C (hold for 30
seconds), ramp 50 seconds to 70°C (hold for 60 seconds)]; 1 cycle of 60°C for 30 minutes
for final extension; and hold 4°C.
2.3.8

Detection and analysis of PCR products
Detection of PCR products did not vary throughout standardization of the process.

A volume of 0.5 µl for each amplified product was mixed with 4.35 µl of Hi-Di™
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Formamide and 0.15 µl GeneScan™ 500 LIZ Size Standard (35-500 bp) (Applied
Biosystems, Foster City, CA) and denatured for 3 min at 95°C and detected on a Genetic
Analyzer AB3130xl (Applied Biosystems, Foster City, CA). Data were analyzed with
software GeneMapper version 4.0 (Applied Biosystems Foster City, CA). Quantification
of the allele size in comparison with the internal lane size standard (Genescan 500 LIZ
size standard) was scored for each sample replicate per marker.
2.4
2.4.1

Results
Single tandem repeats are located near embryonic developmental genes
Three hundred twelve STR markers were initially selected by location near

embryonic developmental genes. Sixty-four STR markers were successfully standardized
and organized in 20 different multiplexes. Chromosome location, PCR product length
range, repeat motif, Genebank number, fluorescence dye used for labeling the primer,
concentration, and sequences of each primer are reported for each STR marker
characterized (Table 2.1 and 2.2). From these 64 markers, 11 were related to
pluripotency genes, 33 were related to differentiation genes, 12 were related to chromatin
assembly genes and 8 were related to imprinting genes (Table 2.3).
2.4.2

Size of repetitive markers
Repeat motifs were found to be important determinants for STR marker selection.

STRs with a minimum six repeat units, including those with mononucleotides to
hexanucleotides motifs were selected. Dinucleotides and tetranucleotides are more
common across the genome than trinucleotides and pentanucleotides (Collins et al.
2003). Out of 64 markers that were standardized in section 3.1, 5 are mononucleotides,
45 dinucleotides, 1 trinucleotide, 11 tetranucleotide, and 2 pentanucleotides across the
44

genome (Table 2.1). Note that all these markers are located in intragenic, coding or untranslated regions either upstream or downstream of embryonic developmental gene
promoters.
2.4.3
2.4.3.1

Optimization of PCR conditions in order to detect repetitive sequences
Primer concentration
Primers were standardized in singleplex reaction to determine optimal

concentrations to ensure independent amplification of the STR fragment from the total
DNA in the reaction. Primers showing similar conditions of amplification were
organized in multiplexes of 3 to 5 STR markers in a size range of 100-400 bp to avoid
overlapping of the allele peaks that could impede data interpretation. Simultaneously,
amplified products of these multiplexes were analyzed and the concentration of the
primer was empirically adjusted to achieve a homogeneous height if a multiplex primer
balance displayed heterogeneous allele peak height or some markers failed for
amplification. Several adjustments of primer concentrations were made until optimize
simultaneous amplification of markers in each multiplex without twofold differences in
peak heights were achieved. STR markers were removed if they did not show better or
balanced amplified products in comparison with other STRs. For this reason, some
multiplexes have 3, 4, or 5 STRs each from the total of 20 standardized multiplexes.
2.4.3.2

PCR standard components
A balanced amplification of the STR in multiplexes was obtained using selected

concentrations of MgCl2 at 2.5 mM. In contrast, higher concentrations of MgCl2
displayed an increase of unspecific peaks that negatively affected the data interpretation.
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Final concentration of Taq polymerase was 1.25 U as non-specific differences were
observed with higher Taq polymerase concentrations.
2.4.3.3

PCR standard conditions
Annealing temperature was also tested at three different points: 58°C, 59°C, and

60°C. Protocols of forensic STR standardization have reported that higher melting
temperatures improve STR amplification in multiplexed PCR (Butler et al. 2001). We
found that 59°C was an optimal annealing temperature to our multiplexes observing that
58°C allowed poor amplification of some markers and 60°C increased non-specific
amplifications.
Number of amplification cycles varied among 30, 35 and 40. The optimal cycle
number was set at 35 due to the fact that all markers displayed an average peak height in
a range of 1000 to 2000 relative fluorescent units (RFU) at single DNA genome
equivalent concentration. After 40 cycles of amplification, non-specific peaks appeared
and interfered with allele identification.
The final extension step of PCR protocol allows the addition of adenines to the 3’
end of the double strand DNA during 30 minutes at 60°C. This step minimizes split
peaks, ensuring that all amplified products are the same length and optimal shape. This
facilitates differentiation of wild type and mutated alleles (expanded or contracted)
(Brownstein et al. 1996).
2.4.4

PCR enhancers increased successful amplification of STR multiplexes
Some samples showed low amplification rates using initially standardized

conditions. During the experimental process, reagents known as enhancers of PCR were
added to increase the success of amplification of GC rich templates and difficult
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templates in very low DNA concentration considered as single cell genome equivalents,
or templates that could make secondary structures (Chakrabarti and Schutt 2001; Haqqi et
al. 2002; Hubé et al. 2005). Dimethylsulfoxide (DMSO) and bovine serum albumin
(BSA) enhancers were used in our multiplexes in order to improve the optimization for
PCR amplification of these markers using single cell DNA equivalent concentration.
DMSO at 2% concentration did not show significant differences on the amplified
products on the multiplexes in comparison with high concentration of 4% that show
impact on the amplification balance between markers in the multiplex. Literature reported
that DMSO decreases hydrogen bond formation between DNA strands giving a higher
yield of PCR amplification products (Varadaraj and Skinner 1994; Sahdev et al. 2007).
In addition to enhanced multiplex amplification affected by the excess of residual
dye from the multiple primers, we used BSA to help stabilize and enhance DNA
polymerase activity during PCR amplification (Butler et al. 2001; Eilert and Foran 2009).
In the absence of BSA, PCR amplification of a 4 marker multiplex displayed low peak
heights in 3 markers (vWA, TPOX, FGA) and failure for the amplification of one marker
(D8S1179). In contrast, when BSA was added into the PCR reaction at a concentration
of 0.4mg/ml, BSA enhanced the simultaneous amplification of the same 4 heterozygous
markers resulting in balanced peak heights (Figure 2.1). The results did not show
differences when low concentration of BSA 0.2mg/µl was used.
2.4.5

Residual dye artifacts
After PCR amplification, some primers displayed dye artifacts due to residual dye

impurities from manufacturing processes, improper primer storage that induces primer
light degradation or continuous freeze/thaw conditions. Filtration of PCR amplified
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products is recommended to remove free dye labels that can interfere with data
interpretation and allele designations (Smith and Ballantyne 2007). Residual dyes from
some markers were observed and they were identified as a background on the negative
control products (Figure 2.2). To help prevent dye artifacts, primers were stored protected
from light exposure and in small stock aliquots to ensure primer stability. Negative
controls were exhaustively analyzed to differentiate real alleles and background dye
signals on specific markers.
2.4.6

DNA concentration as a determinant factor on STR multiplexes validation
Large pool PCR amplification (500 and 75 pg/µl of DNA concentration) and

single genome equivalent PCR amplification (50 and 25 pg/µl of DNA concentration)
were optimized to ensure sensitivity and the efficiency of multiplexes in detection and
discrimination of wild type and mutate alleles in their corresponding frequencies.
Identification of the wild type allele was achieved by PCR amplification with large DNA
concentration in comparison with low DNA concentration or single DNA genome
equivalents that allow amplification of wild type or mutate allele in each sample
replicate.
Using more than 500 pg/µl of DNA induced an amplified product with intense
fluorescence that impacted the optimal wild-type and mutated alleles discrimination. This
is in contrast to using lowest DNA concentration (below 25 pg/µl) that displayed poor
amplification by low peak heights (below 100 RFUs) or complete absence of
amplification on some STRs multiplexes this caused great difficulty in the analysis and
interpretation of the data. Therefore, the final DNA concentration used to determinate
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single tandem repeat instability between samples in these markers was between 25 to 50
pg/µl.
2.5

Discussion
STR markers have been cataloged as a useful tool in studies of disease detection

and progression. The presence of expansion or contractions of STR markers may be a
genetic signal responsible for losses of DNA integrity that induce cell transformation.
Disruption of STRs has been involved as a signal that contributes to deregulation of gene
expression in cells. Therefore, studies of genomic instability by STR markers have
demonstrated the utility of those markers to predict susceptibility to disease mainly
during tumorigenesis.
ES cells have been isolated and maintained in vitro during several passages. Some
reports have shown that chromosomal aberrations accumulate after long term passages of
ES cells (Amit et al. 2000; Maitra et al. 2005). The aim of this study was to determine if
STR instability was present during ES cell in vitro passages. STR markers located near
pluripotency and differentiation genes were identified and standardized by PCR. These
STR markers optimized could constitute novel biomarkers that useful for determination
of ES cell genomic instability. Characterization of STRs is an important tool for
determining the status of DNA integrity during ES cells in vitro culture maintenance.
This study demonstrated that these multiplexes are robust and have efficient
reagent concentrations and PCR conditions to amplify ES cell samples regardless of the
DNA concentration amplified, large DNA concentration as well as single cell DNA
equivalent concentration. Strict primer design and PCR conditions are key elements for
creating successful multiplexes and ensuring cost-effective advantages by simultaneous
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PCR amplification of different STRs of interest. The ability to determine product
amplification and separation characteristics, such as stutter (artifact peaks preceding the
true allele peak) or unspecific amplification artifacts, allowed us to determine the specific
range of normal and abnormal allele shifts per STR marker. This was an important
observation when determining accurate mutation frequencies for unstable repeat motifs in
independently tested sample replicates.
The reported multiplexes will facilitate the genetic integrity evaluation of ES cell
samples at different times of in vitro culture. In addition, the present molecular technique
will open new doors to discovery and validation of new and informative STR markers
that could be used to determine predisposition, susceptibility, diagnostics, and
prognostics of abnormalities occurring during early embryonic development.
These PCR combinations significantly impact the sensitivity for detection of
alleles in their accuracy frequency. Standardization of STR multiplexes is a combination
of careful primer design, optimization, and evaluations of PCR reagents and conditions
needed for robust and balanced STR peaks amplification independent of the DNA
concentration. Additional validations are needed to predict STRs informativity and which
of them could give the major sensitivity in ES cell genomic integrity evaluation.
Application of STR analysis for detection of genomic instability losses allows the
identification of target repeat elements on the genome. Instability in STRs involved
during improper ES cell signals in vitro may have the potential to increase the knowledge
about ES cells pluripotency maintenance or cell fate initiation early in embryonic
development. In conclusion, specific STR markers could be identified as informative
markers allowing the characterization of ES cells as a safe source of cells for regenerative
applications.
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Table 2.1

Characteristics of single tandem repeats analyzed
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Table 2.1 continued
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Table 2.2

List of single tandem repeat primers sequences
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n. Marker name

Primer
Label
volumen
dye
(µl)

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21

FAM
HEX
FAM
FAM
FAM
FAM
FAM
FAM
FAM
FAM
FAM
FAM
HEX
HEX
HEX
FAM
HEX
HEX
HEX
FAM
FAM

NANOG
D16S3034
D12S1719
D3S1541
D1S1656
D1S551
D4S2623
D12S1682
D11S4090
D2S134
D1S2630
D11S1331
D6S2384
D7S488
D6S1001
D4S1625
HISTH4A
HISTHB2
D10S529
D22S447
D1S430

0.4
1
1
1
1
1
1
0.8
0.8
1.6
0.8
0.8
1
0.7
1.5
1
1
0.6
1
0.6
1.7

Primers sequence
GAAAGAAAGAAAAGAAAGAAAAAGAAA TGACTTCATCCTAATCAACAGCA
TAATCTAGTTAAAGATGCAACTGCC
GCTCAGAAGTTTTGATGCC
TCCTCCAGTTTCAGTAATGTTT
TATGGACTGTAAGAAATGCCA
GTGTTGCTCAAGGGTCAACT
CTGCCAGAGAATAGGGTGAA
AACTAGGCTGCTTCCCAGAT
GGGACAAGAGTGAGACTTGG
GAGAGTGGGTCAGGTCG
AACGTCTGCTCGTCAGAGTC
CCCAGAAGGTTGAGAGTGC
GCTGCTTCCATGAGAGGATACTG

GGTGGTTGATGCCTGTAA
TGTGGGGTGGATAGAAAGAG
GAGAAATAGAATCACTAGGGAACC
TTGTAATTCTTGGTCCTGCC
GCCAGATACATGGCTAAGGA
CCTTTATTGAAGTAAACTGTGAAGC
GCTGCAGTTTCGGGAA
CGACTACGTGCTGGCTACTT
CAGTAATCCCATAGACAGTAAATCG
GCAGAGCCCTTTGCAGTCTT

ATGTCTCCTGCGAAGTAG
ACCTCTCCCTGACCTCATTA
gtttcttTCTGGGATTCCTGTCCAATG
GACTCCAAATCACATGAGCC

GAAGTCTGAAAAAGTCTGATTG
AAAAAATAAGCCAGCAAGGA
CCTGACATATAGTAGGCACTC
GTCTCTGCATTTGCTGGTTT

GCTCACGCCTGTAGTCACTG
AAGTTTGCTTTCGGTTTTCG
AGCAGGCGCTAGACTGTGAC
AGCACAGGAAGGAAGCTGTT
TCCAGATTTAGTGTCATTTCCC

TGCACCCAGTGTGTAGGTTT
CGGCACTGCACTTCATCCT
AGTGATGCCTTGCAGATGCT
GTTGGCAGATGCTTCAGGA
CACTTACAGTAACAAGCCCCAG

Table 2.2 continued
Primer
Label
volumen
n. Marker name
dye
(µl)
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22
D2S290
FAM
23
D6S416
FAM
24
D2S2327
HEX
25
D8S11268
HEX
26
kLF4-1
HEX
27
NANOG
HEX
28
D3S1583
HEX
29
DXS458
HEX
30
D22S941
HEX
31
D9S1840
HEX
32
D7S638
HEX
33
D21S1909
HEX
34
D6S1698
HEX
35
D2S144
FAM
36 GRB10PROM FAM
37
D10S1653
FAM
38
G60405
FAM
39
D11S909
HEX
40
D6S2252
HEX
41
D5S2021
FAM
42
D20S821
FAM

0.8
0.9
0.7
1.1
0.9
1.2
1
1
1
1
0.6
1
1.2
1.3
0.6
1.3
1
0.8
0.8
1.2
0.8

Primers sequence
CGACTCTGGTGAATTGCTTG
GGCCCCACTTCCAGTAAGG
CAACTGAATTTTTCAGACTTGTC

CGACTCTGGTGAATTGCTTG
GGCCCAGGATAAAATGGTTG
AATTAGAGCCAGATTTTAAAGGA

GACATTTCACCGGATTTGAG
CAACCTTGGGAGAATGGAGA
GAGGCGGAGGTTACAGTGAG
AGCTTGTAAATAGGTCCTAACAGAG
GATAAAACTGCATAGAAATGCG

TCTCTCTCCCTTTTCCCTTG
GCCTGGGCAATAGAGTGAGA
GGGGCTTTTCATCCAAAAA
TGGTTTAATAGGCACCGTTT
CAACTGGGATATTGACATTG

CAGGTTACAAAGTACATTAACTT
ACCAATCAGAAACCTTGCC

CAAGAAATGGTTGGAGCTGGT
TTAAGAACAGAAGCGCATAGGAG

GCCAAAGGAAGGTTAAGTGT
CTGTGATTGTGTTTTCCATTTAGCA
TGCAGGTAATTTGACTACCC

CCACGCATATATGTACAGCA
TTCCACACTGAGTCAAGAGCAGG
ACACCCCTCATATATACTTGAGTGT

TCTCCCTGACAGACTCTGCG
ACAGCATTATGGCTGCAAAA
CCTTTGGATAAAGCCTCCT
CTTAGAGTCTCATGGGAAAAACAGAC
GATATAACACCAAAAGCGCG

GCTGCATAGGCCGTACTGAG
TTGGCTTTGTGTCACATTCG
TATCATTGTCTCATCCGGG
AAAATTTCACACGTTGTTTCCTTG
GGTATTCTTACAGCACAAAAGTTCT

CTAATCTCCAAATGCCTAAG
TTCT1.2ACGGATTCCAATCAC

GATTTAGAAATGTAGGCCAG
CAAAAGCAACTTAACCACG

ACAGGAAATAAACTAGGCATGAGG

CAACTCGATGAAACTAAGATTTCAAC

Table 2.2 continued

n.
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Primer
Label
volumen
Marker name
Primers sequence
dye
(µl)
IGF2R
FAM
1.2 TTCTACGGATTCCAATCAC
GTATCATGAGAACCTGAAGAG
AGCTCATGTTGGATGTATCA
GTCAGACTACGCGCCTT
D18S63
FAM
1
DIRAS3PROM FAM
0.8 TCTCTTCACATCTGGAAACTTCA
GCCTGGGTAACATAGGGAGA
CTTTTCAAAGATCGACTCCAGTG
ATTCTCCCAGATAGCAGGGC
D4S1542
FAM
1
DXS981
FAM
2
TCAGAGGAAAAGAAGTAGACATACT
TTCTCTCCACTTTTCAGAGTCA
D14S588
FAM
1
GCCGAAAGAAAGAAAAAAGG
CGAATGCATACTTGCTGTTG
CTGGTTTGGGTCTGTTATGG
AGGGACTTAGAAAGATAGCAGG
D3S2459
FAM
1
CCCCAAGGCTGCACTT
AGCTGAGACTACAGGCATTTG
D3S1611
FAM
1
D17S2180
HEX
1
GCGTCGAGTTTTCACATCTT
TAGTCTTGTCTTAGCTCTGGACG
GTTTGAAGAATTTGAGCCAACC
TTCTTCTGCACACTTGGCAC
EGFR
HEX
1

43
44
45
46
47
48
49
50
51
52
53 PEG10PROM
54 SNURF10PROM
55
D16S3091
56
D1S468
57
TNFa3
58
DNMT3
59 IGF2PROM
60
D15S983
61
IGF
62
DXS1208
63
D5S426
64
D11S2179

HEX
HEX
FAM
FAM
FAM
FAM
FAM
FAM
HEX
HEX
HEX
HEX

1
1
1
1
1
1
1
1
1
1
1
1

GGGCAATTGCATTCTTGG
ATTGCACCATTGCACTCCAG
GGGAGATAGCCTTAAACTTTCTTAC
AATTAACCGTTTTGGTCCT
CCTCTCTCCCCTGCAACACACA

GGATGCTGATGCTGAACTGG
TCTAATTTGGGAACATGACTTCC
TGTTGCTAATAACACTAGGCCA
GCGACACACACTTCCC
GCCTCTAGATTTCATCCAGCCACA

AACCCAGGTAGCCAGAGACC
CGGGAGATTATCGGGTTTG
TCTGAAACGATGGGCTG

CCTGTCATCCTGCTTTGGA
GCGCCGCCTTCCACATTAGA
AAGGTGATTCCGTCCCTG

GCTAGCCAGCTGGTGTTATT
CGGCACGTAAGGACAG
AAATTCTTGCTTTCATAGCCA

ACCACTCTGGGAGAAGGGTA
GTTAAAGGATTTGGGAGGC
AGACTAAATAAAATCACTGCCG

TAGGCAATACAGCAAGACCCTG

GCACTGGAATACGATTCTAGCAC

56
Figure 2.1

Examples of electropherograms
electropherograms.

Notes: Top panel shows PCR amplification results in the absence of bovine serum albumin (BSA) that clearly indicates a failur
failure for
the amplification of marker D8S1179 and the other markers in this panel display low peak heights. The bottom panel shows PCR
amplification results with addition of 0.4mg/ml of BSA and displays how BSA enhanced the simultaneous amplification of the
same 4 heterozygous markers. Both panels are amplifications from the same DNA sample and PCR conditions, with the exception
of addition / absence of BSA.

Figure 2.2

Examples of Electropherograms

Notes: Twenty fluorescent multiplexes of 62 single tandem repeats markers standardized
are shown in these panels. Names for each marker are shown above the corresponding
peak. Alleles are distinguished by different colored peaks. Each marker is either 6-FAM
(blue) or HEX (green) labeled. The base pairs (bp) size of the alleles is shown below each
corresponding peak. Panel (A and B) Multiplex 1 (OCT*4 and D16S3034 markers).
Panel (C) Multiplex 2 (D2S1719 and D3S1541 markers). Panel (D) Multiplex 3
(D12S1682, D11S4090, D2S134, and D1S2630 markers). Panel (E) Multiplex 4
(D1S1656, D1S551, and D4S2623 markers). Panel (F and G) Multiplex 5 (D11S1331
and D6S2384 markers). Panel (H and I) Multiplex 6 (HISTH4A, D4S1625, D3S1583,
DXS458, and D22S941 markers). Panel (J and K) Multiplex 7 (HISTHB2, D10S529
D22S447, D1S430, D2S290, and D6S416 markers). Panel (L) Multiplex 8 (D2S2327,
and D8S11268 markers). Panel (M) Multiplex 9 (D9S1840, D7S638, D21S1909, and
D6S1698 markers). Panel (N) Multiplex 10 (D2S144, GRB10-PROM, D10S1653, and
G60405 markers). Panel (O) Multiplex 11 (D6S2252, D11S909, D2S2333, and D5S2115
markers). Panel (P) Multiplex 12 (DIRAS3-PROM, D4S1542, and DXS981 markers).
Panel (Q) Multiplex 13 (D5S2021, D20S821, IGF2R, and D18S63 markers). Panel (R)
Multiplex 14 (D14S588, D3S2459, and D3S1611 markers). Panel (S and T) Multiplex 15
(D17S2180, EGFR, D16S3091, and D1S468 markers). Panel (U) Multiplex 16 (PEG10PROM and SNURF2-PROM markers). Panel (V) Multiplex 17 (IGF2-PROM and
D15S983 markers). Panel (W) Multiplex 18 (D7S488 and D6S1001 markers). Panel (X)
Multiplex 19 (TNFa3 and DNMT3 markers). Panel (Y) Multiplex 20 (IGF and DXS1208
markers).
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Figure 2.2 continued

58

Figure 2.2 continued
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Figure 2.2 continued
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Figure 2.2 continued
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Figure 2.2 continued
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Figure 2.2 continued
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CHAPTER III
EMBRYONIC STEM CELL GENOMIC INSTABILITY RESULTING FROM
CULTURE PASSAGES MAY BE A MECHANISM OF ADAPTATION
AND PLURIPOTENCY MAINTENANCE
3.1

Abstract
Embryonic stem (ES) cells have the ability to maintain pluripotency and self-

renewal during in vitro maintenance, which is a key to their clinical applications. ES cell
quality has been widely evaluated through determination of the specific genetic and
epigenetic profiles. The hypothesis of this study was that genetic stability in repetitive
sequences located near key genes involved in pluripotency, self-renewal, differentiation,
chromatin assembly, and imprinting could be a signal for adaptation of the ES cell in
vitro. Instability in specific repetitive sequences is present and increases during ES cell
passages. ES cells displayed significant mean frequencies of instability in twelve markers
out of 64 related to pluripotency (OCT4, D1S551), early differentiation (G60405,
D18S63, and D1S468), chromatin assembly (D22S447, D6S2252, D10S529, and
HISTB2), and imprinting (GRB10-prom, D2S144, and IGF2-prom). Interestingly,
instability was distinct between H1 and H7 ES cell lines. In summary, these results
suggest that instability in tandem repeat sequences located near early embryonic
developmental genes is associated with failure of ES cell pluripotency and self-renewal
maintenance over consecutive culture passages. These results suggest that instability
determination is a potential indicator of gene deregulation and epigenetic modification
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that involves chromatin modification and imprinting establishment during ES cell
cultures. Finally, instability in specific genes could be a signal that contributes to
adaptation of ES cells to in vitro culture or could be the switch that initiates early cell
specialization in vitro.
3.2

Introduction
Since the first human embryonic stem (ES) cells were isolated two decades ago,

this field of research has generated uncountable advances and knowledge about early
embryonic development and cell fate differentiation (Evans and Kaufman 1981;
Thomson et al. 1998; Brimble et al. 2004; Enver et al. 2005). ES cell pluripotency and
self-renewal led to significant discoveries and clinical applications as the source of all
cell types from the three embryonic germinal layers. However, continued maintenance in
vitro leads to cellular, genetic, and epigenetic changes in the ES cells, which creates
many questions about their real therapeutic potential. The accepted culture conditions
used for ES cell maintenance around the world are limited. ES cell research continues to
face doubts about their clinical applications because of a wide range of variability in the
maintenance of homogeneous and undifferentiated ES cells over time during culture
passages (Toyooka et al. 2008; Ying et al. 2008).
Several studies have reported changes in ES cell gene expression profiles that
occur during long term cultures (Abeyta et al. 2004; Brimble et al. 2004; Xu et al. 2005).
Also, the presence of chromosomal abnormalities in late passage cultures of ES cells has
been reported (Amit et al. 2000; Draper et al. 2004; Inzunza et al. 2004; Maitra et al.
2005; Ogawa et al. 2006). Furthermore, the signals or initial steps that lead to gene
expression and epigenetic changes remain unknown. A simple screening method to select
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the best ES cells would be of great use in the field. This study focuses on determining the
role of instability in repetitive DNA sequences as a signal of ES cell adaptation or
differentiation, and the identification of possible biomarkers useful for screening and
determining the quality of ES cells to be used for regenerative therapies.
Instability in flanking regions of developmental genes could affect enhancer or
repressor elements that regulate transcriptional patterns of ES cells during in vitro
maintenance. In order to understand how genomic instability affects pluripotency of ES
cells, self-renewal, and differentiation, we have tested a key characterization method to
evaluate the safety of the ES cell treatments. As a first step to investigate the instability
effects of repetitive sequences on ES cells over time, we have determined the mean
frequency of instability in different markers located in close proximity to sequences of
important genes responsible for ES cell pluripotency, self-renewal, cell differentiation,
chromatin assembly, and imprinting. We analyzed H1 and H7 ES cell lines during early,
middle, and late passages to compare the genomic instability across passages. By
determining the mean frequencies of instability for each marker, we identified sensitive
repetitive markers that showed significant instability in ES cell cultures over time. In
addition, specific genes that were identified as related to the unstable marker were
evaluated. This study has established that instability in these specific regions could
modulate gene expression and epigenetic signals that determine ES cell adaptation or
differentiation stages.
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3.3
3.3.1

Materials and Methods
Embryonic stem cell maintenance
Frozen aliquots from human ES cells H1-WA01 passage 27 and H7-WA07

passage 26 were purchased from the National Stem Cell Bank – Wisconsin International
Stem Cell Bank (Appendix B). H1 and H7 ES cells were seeded onto a mouse embryo
fibroblast-CF1 (MEF) feeder layer previously inactivated with mitomycin C. The culture
medium consisted of Dulbecco’s Modified Eagle Medium (DMEM) knockout medium
(Invitrogen, Carlsbad, CA) supplemented with 10% knockout serum replacement
(Invitrogen, Carlsbad, CA), 1% antibiotic-antimycotic (Invitrogen, Carlsbad, CA), 100
µM β-mercaptoethanol (Sigma Aldrich Saint Louis, MO), 20 ng/ml basic fibroblast
growth factor (b-FGF) (Invitrogen, Carlsbad, CA ), 1% non-essential amino acids
(Invitrogen Carlsbad, CA), 2 nM L-glutamine (Invitrogen, Carlsbad, CA), and 20 ng/ml
of leukemia inhibitor factor (LIF) (Chemicon/Millipore Billerica, MA). ES cells were
maintained in a humidified atmosphere at 37°C in 5% CO2. Medium was changed daily.
3.3.2

Mouse embryo fibroblast CF1 feeder layer
The mouse embryo fibroblast (MEF-CF1) feeder layer cells were purchased from

American Type Culture Collection (ATCC, Rockville, MD) (Appendix B). MEF feeder
layer cells were cultured in a T-25 flask (Falcon, Becton Dickinson Labware, NJ). The
culture medium consisted of DMEM high glucose medium supplemented with 10% heatinactivated fetal bovine serum (FBS) (Invitrogen, Carlsbad, CA) and 1% antibioticantimycotic (Invitrogen, Carlsbad, CA). MEF cells were mitotically inactivated for 2
hours with 10 mg/ml mitomycin C (Sigma Aldrich, Saint Louis, MO), seeded at densities
of 130,000 cells/ml in gelatin coated one-well dishes (Falcon, Becton Dickinson
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Labware, NJ) and cultured 24 to 48 hours before ES cells were seeded onto the feeder
layer. These cells were maintained in a humidified atmosphere at 37°C in 5% CO2.
3.3.3

Embryonic stem cell passages
ES cell colonies with undifferentiated morphologies were mechanically dissected

into small pieces under a stereomicroscope and seeded onto a fresh MEF feeder layer
during 20 passages (5 months). Cells were passaged every 4-6 days (Figure 3.1).
Periodically, ES cells were tested for the presence of alkaline phosphatase activity, which
is an indicator of the undifferentiated state. We used the alkaline phosphatase detection
kit following the manufacturer’s recommended protocol (Millipore, Chemicon, Billeria,
MA). Sqamples of ES cell colonies were dissected for isolation of DNA and RNA early
in the culture time (passage 27-28) and during the middle of the culture time (passage 4042) in both ES cell lines.
3.3.4

Immunohistochemical analysis
ES cell colonies were fixed with 4% paraformaldehyde (Sigma Aldrich, Saint

Louis, MO) for 15 minutes at room temperature, washed in PBS, and immunostained.
The primary antibodies used were rabbit anti-OCT4 polyclonal antibody, mouse antiSOX2 monoclonal antibody, and mouse anti-SSEA-1 alexa fluor 488
(Chemicon/Millipore, Billerica, MA). Secondary antibodies included goat-anti-rabbit IgG
rhodamine and C5Y-conjugated antibody (Chemicon/Millipore, Billerica, MA). Each
antibody was diluted 1:200 in PBS, 0.1% Triton X-100, and 3% BSA. Nuclei were
visualized with 4’-6-diamidino-2-phenylindole (DAPI) staining (Vysis Abbott
Laboratories, Abbott Park, IL). Staining without primary antibody served as a negative
control. Images were captured using a fluorescence microscope Axiovert 135 (Carl Zeiss
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International) with FITC and rhodamine filter set. Fluorescence intensities were
measured with image software developed at the National Institute of Health (Bethesda,
MD) downloaded from http://rsb.info.nih.gov/ij/index.html. Accumulation was calculated
by averaging the fluorescent ratio between exposed and non-exposed areas in the nucleus.
3.3.5

DNA isolation
DNA was prepared from each sample of ES cells in early passage (27-28) and

middle passage (40-42). DNA from late passage (78-82) was provided by the Michigan
Center for human ES Cell Research (Ann Arbor, MI). DNA was isolated with the
Purelink genomic DNA mini kit (Invitrogen Carlsbad, CA) following the manufacturer’s
protocol. All DNA samples were quantified using a NanoDrop™ ND1000
spectrophotometer (Thermo Scientific, Wilmington, DE).
3.3.6

Single tandem repeat markers selection and standardization
Single tandem repeats (STRs) are located in or near promoter regions of specific

genes responsible for embryonic stem cell pluripotency and self-renewal. We identified
DNA sequences that were approximately 1000 bp upstream or downstream of the
promoter using UCSC Genome Browser (http://genome.ucsc.edu/cgi-bin/) gene sorter
and uni-STS-NCBI database (http://www.ncbi.nlm.nih.gov/genome/sts/sts.cgi). A total of
64 STR were selected and classified according to ES genetic network regulation database
available at (http://www.wi.mit.edu/young/hESregulation/). Eleven markers were related
to pluripotency genes, 33 were related to differentiation genes, 12 were related to
chromatin modification genes, and 8 were related to imprinting genes (Table 3.1). Each
STR was optimized to obtain amplified products with robust signal intensity and
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balanced peak heights from ES cell samples in early passage (27-28), middle passage
(40-42), and late passage (78-82).
Samples were analyzed with differing amounts of genomic DNA: large DNA
concentration (DNA concentration of 0.1 to 1 ng/µl) and single cell DNA concentration
(single genome equivalent between DNA concentrations 12.5 to 50 pg/µl). The average
for amplifiable DNA (λ) was calculated by Poisson distribution: λ= - ln (number of
replicates with non-amplification / total number of replicates) (Zhang et al. 2002). A λ <
2 means that single genome equivalent of DNA was present in the amplification.
Each locus was standardized in separate PCR reactions to optimize and ensure
specificity and sensitivity of the system. Labeled primers with either 6-FAM or HEX dye
were used to allow automatic detection. Primers were tested at concentrations of 0.8-1.5
µM in standard PCR conditions and reagents.
3.3.7

Genomic instability determination by single cell PCR
Single cell PCR was performed on 64 STRs (Table 3.1). Less than a single diploid

genome-equivalent of DNA (25-50 pg/µl), was used to perform single cell PCR analysis
in 48 replicates for each marker. These concentrations of DNA ensure sensitivity of the
PCR to detect wild type and mutated alleles at their appropriate frequency (CoolbaughMurphy et al. 2004). Total reaction volume of 10 µl containing 1X of buffer D (800 mM
Tris HCL, 200 mM (NH4)2SO4, 0.2% w/v Tween 20) (US DNA, Fort Worth, TX), 2.5
mM of MgCl2 (US DNA, Fort Worth, TX), 1.25 U of Hot-MultiTaq DNA polymerase 5
U (US DNA, Fort Worth, TX), 4% of DMSO (Sigma Aldrich, Saint Louis, MO), 0.4
mg/ml of BSA (Thermo Scientific, Rockford, IL), 300 µM of dNTPs mix (Applied
Biosystems, Foster City, CA), and 1X of Solution L 5X (enhancer solution for
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amplification of difficult templates) (US DNA, Fort Worth, TX). The primer
concentration for each primer is shown on Table 2.2 in CHAPTER II.
PCR was performed on a PE 9600 thermocycler using a ramping protocol: 1 cycle
of 95°C for 11 minutes; 1 cycle of 96°C for 1 minute; 10 cycles of [94°C for 30 seconds,
ramp 68 seconds to 58°C (hold for 30 seconds), ramp 50 seconds to 70°C (hold for 60
seconds)]; 25 cycles of [90°C for 30 seconds, ramp 60 seconds to 58°C (hold for 30
seconds), ramp 50 seconds to 70°C (hold for 60 seconds)]; 1 cycle of 60°C for 30 minutes
for final extension; and hold 4°C. Negative controls per run were included to check for
contamination.
Amplified products were mixed with Hi-Di™ formamide and GeneScan™ 500
LIZ Size Standard (35-500 bp) (Applied Biosystems, Foster City, CA) and denatured for
3 min at 95°C to be separated and detected by fragment analysis on a Genetic Analyzer
AB3130xl (Applied Biosystems, Foster City, CA). Data were analyzed with the software,
GeneMapper version 4.0 (Applied Biosystems Foster City, CA). Quantification of the
allele size in comparison with the internal lane size standard was scored in each single
cell replicate. An average of 48 replicates per sample plus negative controls were
amplified and scored for both ES cell lines.
STR makers are classified according to their repeat motif (number of
nucleotides): mononucleotides (1 nucleotide motif), dinucleotide (2 nucleotide motif),
trinucleotide (3 nucleotide motif), tetranucleotide (4 nucleotide motif), and
pentanucleotide (5 nucleotide motif). Wild type alleles were determined for each
microsatellite. Repeat motif shifts from the wild type allele size were considered a mutant
allele. Mutant alleles for mononucleotides (e.g. GRB10-PROM, IGF2-PROM, and
HISTBH2) were determined by a repeat shift greater than 3 repeats or less than 3 repeats.
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For dinucleotides (e.g. D18S63, D6S2252, and D10S529), mutants were determined by a
repeat shift greater than 2 repeats or less than 3 repeats. For trinucleotides (e.g.
D17S2180), tetranucleotides (e.g. OCT4, and D1S551) and pentanucleotides (e.g.
DIRAS3-PROM), mutants were determined by a repeat shift greater than 1 repeat or less
than 2 repeats (Figure 3.2) (Boland et al. 1998; Suraweera et al. 2002; CoolbaughMurphy et al. 2004; Coolbaugh-Murphy et al. 2005; Goel et al. 2010).
3.3.8

Statistical analysis of genomic instability
Mutation frequencies (total number of wild type alleles related to the mutant

alleles in each marker) were determined for each ES cell line and passage number by SPPCR software version 2.0 (M.D. Anderson Cancer Center Houston, TX) (Appendix C).
Differences in mutation frequencies were calculated with a two tailed t-test using raw
mutation frequencies using a package SAS/win 9.2 (SAS Institute, Cary, NC). Mutation
frequencies of informative markers were considered statistically significant when a pvalue was ≤0.05, and were considered marginally significant if the p value was ≤0.10.
3.4
3.4.1

Results
Embryonic stem cell culture maintenance
The ES cells were continuously cultured for 20 passages to explore the potential

role of genomic instability during ES cell maintenance in vitro under standard conditions
with MEF and growth factors, such as b-FGF and LIF. ES cells from both cell lines (H1
and H7) retained their growth and morphological characteristics: ES cell showed
homogenous round and compact colonies, ES cells showed a prominent nucleus and high
nucleus: cytoplasm ratio, and ES cells showed positive alkaline phosphatase activity as
well as expression of the specific pluripotency markers OCT4 and SSEA-1(Figure 3.3).
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3.4.2

Embryonic stem cells displayed morphological changes across passages
ES cell cultures, in general, could display less than 20% of the colonies with

heterogeneous morphology corresponding to differentiation. These heterogeneous
colonies were then removed with a pipette under a stereomicroscope before the next
subsequent passage (Adewumi et al. 2007; Veraitch et al. 2008; Kent 2009). H7 ES cells
were subcultured/passaged more than 20 times continuously for more than 5 months.
During that time, they exhibited round and compact colony morphologies. In contrast, H1
ES cells were cultured under the same conditions and time, yet they exhibited an
increased number of irregular shapes of colonies with some differentiated cells at the
periphery (Figure 3.4). To explore the ES cell morphological characteristics over
passages, we compared differences in the shape of the colonies between H1 and H7 ES
cells; we quantified the number of regular and irregularly shaped colonies from passages
28-42 in H1 ES cells and 27-42 in H7 ES cells. We found that H1 ES cells showed a
significant increase in the colonies that exhibited signs of cell differentiation across
passages in comparison to the H7 ES cell line (p=0.04). H1 ES cells in passage 40
showed a higher percentage (37%) of irregular colonies when compared to passage 27
(14%) (p=0.047) (Figure 3.5). H7 cell line did not show any significant difference across
passages. Taken together, these results indicate that H1 ES cells failed to promote
complete self-renewal of the ES cells across passages.
3.4.3

Genomic instability in single tandem repeat markers mediated embryonic
stem cell culture adaptation
Because embryonic stem cells in culture maintain pluripotency and self-renewal

via genetic rearrangements (Amit et al. 2000; Brimble et al. 2004; Draper et al. 2004;
Inzunza et al. 2004; Maitra et al. 2005; Ogawa et al. 2006), we asked whether ES cell
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cultures are genetically stable in long term cultures. The efficiency of ES cells to
maintain genomic stability was evaluated by analyzing single tandem repeat markers
found close to specific genes involved in ES cell pluripotency and self-renewal (Table
3.1). Samples of DNA from H1 and H7 ES cells at three different times (early, middle,
and late passages) were analyzed to determine genomic instability in specific markers.
There was significant genomic instability in 21 out of 64 single tandem repeat markers
evaluated. Both ES cell lines were unstable over passages in these markers. However, H1
ES cells became much more unstable than H7 ES cells. H1 ES cells showed significant
instability differences between early to middle (p=0.002) and between early to late
passages (p=0.025) but differences were not significant between middle to late passage.
In contrast, H7 ES cells show a significant difference only between early to middle
passage (p=0.057) (Figure 3.6). These results indicate genomic instability was present
during long term ES cell cultures and suggest these could be a signal of cell adaptation.
3.4.4

Genomic instability could be a signal of embryonic stem cell pluripotency
and self-renewal loss during long term cell culture
Increasing evidence suggests that culture passages of ES cells lead to significant

changes in gene expression (Abeyta et al. 2004; Brimble et al. 2004; Xu et al. 2005; Gu
et al. 2010). Our results have shown that during long term culture and subsequent
passages, ES cells accumulated instability in single tandem repeats. These markers are
located near important genes involved in pluripotency and differentiation. H1 ES cells
were unstable in three markers related to pluripotency genes (OCT4, D1S551, and
D1S2630) that were completely stable in H7 ES cells over passages. In addition, H1 ES
cell showed instability in eight markers related to genes expressed during early
differentiation (D2S134, D3S1583, G60405, D11S909, D18S63, DXS981, D17S2180,
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and DXS1208). In contrast, H7 ES cells showed instability in three different markers
related to differentiation (D16S3091, D1S468, and D12S1682). Both ES cell lines
showed instability in the differentiation marker DXS1208, but the difference did not
reach significance. Statistically significant differences were observed in two
pluripotency related markers (OCT4 and D1S551) and three differentiation related
markers (G60405, D18S63, and D1S468). D1S551, D18S63, and D1S468 markers
showed higher mean values of mutation frequencies at a significant level (p<0.05)
compared with the other unstable markers analyzed (Figure 3.7 and Table 3.2). We
suggest that the presence of genomic instability in these specific pluripotency or
differentiation genes could be a signal of gene expression changes that induce adaptation
or differentiation of the ES cell during long term cultures and multiple passages.
3.4.5

Epigenetic changes that occur during embryonic stem cell in vitro culture
could result from genomic instability
Imprinting, chromatin assembly, and methylation are essential epigenetic

mechanisms that modulate ES cell maintenance (Bibikova et al. 2006; Collas 2009;
Ahmed et al. 2010). We found significant differences in ES cell genomic instability
following passages. H1 ES cells showed instability in three markers (D22S447,
D6S2252, and D10S529) and H7 ES cells in two markers (D10S529 and HISTHB2) that
were related to chromatin assembly (Figure 3.8 and Table 3.3). All four chromatin
assembly markers were significantly unstable. D22S447 and D6S2252 showed higher
mean values of mutation frequencies at significant levels (p<0.05). Instability of the
HISTHB2 marker was highly statistically significant in the H7 ES cells (p <0.001). H1
and H7 ES cells showed significant instability differences in the D10S529 marker
(p<0.03) (Figure 3.8). Additionally, unstable markers for imprinting genes were
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determined. A single tandem repeat in the promoter of GRB10 imprinting gene was
found to be unstable in both H1 and H7 ES cells, with a significant difference between
them (p=0.026) (Figure 3.9) (Table 3.4). H7 ES cells also showed high instability in two
additional markers (D2S144 and IGF2-PROM), whereas H1 ES cells were stable for
these markers. D2S144 was significantly unstable compared with the IGF2-promoter
marker that showed less significance (p=0.04 and p=0.08 respectively) (Figure 3.9 and
Table 3.4). These findings related to instability of markers located near genes that
participate in epigenetic modifications support the idea that genomic instability could be
essential to generating epigenetic modifications during ES cell maintenance in vitro.
3.5

Discussion
Embryonic stem cells have the capacity for unlimited stem cell proliferation and

the ability to differentiate into all cell lineages from the three germinal layers. Questions
about the molecular signals of pluripotency and self-renewal maintenance in vitro are still
unsolved and are the key to clinical ES cell applications. We evaluated early
developmental molecular markers responsible for pluripotency and cell differentiation
characteristics of ES cells to determine the genomic stability
Accumulation of DNA damage is observed during cellular stress responses. ES
cells in long term cultures have shown genomic instability in the form of chromosomal
abnormalities after more than 100 passages in response to environmental changes during
in vitro maintenance (Amit et al. 2000; Draper et al. 2004; Inzunza et al. 2004; Maitra et
al. 2005). Genomic instability in single tandem repeats create frame-shift mutations,
enhancer, or repressor modifications that originate gene expression changes affecting
cellular processes, which has been explored widely in tumorigenesis studies (Cahill et al.
79

1998; Roelofs et al. 2000; Smiraglia and Plass 2002; Kremenskoy et al. 2003; Gorringe
et al. 2005).
ES cells and tumors have common molecular pathways that maintain their cellular
characteristics and functions (Summersgill et al. 2001; Sperger et al. 2003; Wang et al.
2004; Andrews et al. 2006; Baker et al. 2007; Barber et al. 2008). Instability analysis of a
single tandem repeat located downstream or upstream of specific pluripotency and selfrenewal genes is a reliable tool to characterize the genomic stability during ES cell in
vitro. It can be a potential biomarker to predict and evaluate pluripotency losses and
uncontrolled cell differentiation processes during ES cell maintenance.
Our data suggest that instability in pluripotency and differentiation markers is a
signal of balance between culture adaptation of ES cells and the differentiation process
that is observed by morphological characteristics and genetic stability. H1 colonies
became more irregular than H7 colonies through culture passages. Colony irregularities
are morphological signs of differentiation during cell culture and could be related to the
DNA instability found in specific markers located near essential genes responsible for
optimal ES cell functions. ES cells show low instability during early passages when
compared to the mean frequencies of instability during middle and late passages. Several
reports suggest that late passages significantly increase the frequency of chromosomal
instability due to environmental signals from the in vitro system used to maintain ES cell
lines in culture (Amit et al. 2000; Draper et al. 2004; Inzunza et al. 2004; Maitra et al.
2005). Our results support the idea that ES cell lines exhibit different adaptation
processes involved in genomic instability in early and middle passages as a part of cell
adaptation in vitro. However, during later passages, chromosomal instability occurs in
some stem cell lines that enable maintenance of ES cell pluripotency. Some studies report
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that the H1 ES cell line showed trisomy in chromosomes 12 and 17 at 144 passages
(Draper et al. 2004; Maitra et al. 2005; Baker et al. 2007). In contrast, H7 ES cell line
showed trisomy in chromosome 20 and translocation between chromosome 6 and 17 at
passage 209 (Draper et al. 2004; Maitra et al. 2005; Baker et al. 2007). Apparently,
chromosomal instability and single tandem repeat instability occur by independent
processes that happen during long term ES cell culture. H1 and H7 ES cell lines showed
high rates of single tandem repeat instability during passages 27-28 and 42, but instability
frequencies decreased at late passages (78-82 respectively) (Figure 3.6).
Important key findings emerged from our data: failure to maintain pluripotency,
tendency to differentiate, and epigenetic changes over ES cell passages. We identified
twelve unstable markers localized near pluripotency, differentiation, chromatin assembly,
and imprinting genes that play important roles during early embryogenesis. These genes
are involved in specific cell signals that determine genetic and epigenetic modifications
relevant to the ES cell: DNA transcription, cell cycle, cell differentiation, tissue
specification, apoptosis, and DNA repair.
First, ES cell genes for pluripotency and self-renewal are actively expressed and
are responsible for maintaining all characteristics of the ES cell. When genomic
instability occurs around these specific genes, it could lead to loss of pluripotency and
self-renewal in the ES cells. We found two unstable pluripotency markers in H1 ES
cells; OCT4 and D1S551. OCT4 (POU class 5 homeobox 1) is a transcription factor that
plays a role in embryonic development and has been identified as an important gene for
ES cell pluripotency (Ying et al. 2003; Boyer et al. 2005; Masui et al. 2007). OCT4 is
part of the ES cell gene network that regulates pluripotency by transcription regulation.
OCT4, NANOG, and SOX2 are transcription factors that regulate themselves and bind
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common target developmental genes important for ES cell maintenance and embryonic
development (Boyer et al. 2005; Babaie et al. 2007; Chen et al. 2008; FernandezTresguerres et al. 2010). D1S551 is located near a regulator of G protein signaling gene.
G protein is involved in many cell signaling pathways (Strubing et al. 1997; Neves et al.
2002; Charlesworth et al. 2006; Ebert et al. 2006). In mouse ES cells, G protein
signaling is present during early neurogenesis and provides control of neuronal
differentiation. Studies in mice and rat demonstrated that G-protein is a modulator of
calcium channels, neurotransmitter gamma-aminobutyric acid (GABA), and opioid
receptor (Strubing et al. 1997; Rusin and Moises 1998).
Second, several reports have shown how gene expression changes occur during
ES cell culture passages, but the exact mechanism is not clear (Abeyta et al. 2004; Gu et
al. 2010). Accumulation of DNA damage creates changes in gene expression that induce
cell function decline and loss of the cell’s integrity over time (Abeyta et al. 2004;
Brimble et al. 2004; Xu et al. 2005; Gu et al. 2010). Long term cultures and passages
generate ROS that are a source of DNA damage, apoptosis, and cell cycle defects (Wu et
al. 1996; Lengauer et al. 1997; Eden et al. 2003; Allegrucci et al. 2007). For example,
mouse ES cells, after exposure to ionizing radiation, show DNA damage that induces
fibroblast cell differentiation (Saretzki et al. 2004; Maynard et al. 2008). From our
results, we believe genomic instability could be a signal of gene expression deregulation.
Early embryonic differentiation genes show genomic instability in H1 ES cells over
multiple passages. H1 ES cells cannot completely maintain pluripotency, whereas H7 ES
cells can. Differentiation markers that show instability in H1 ES cells were D2S134,
D11S909, D18S63, and DXS981. Interestingly, these are specific markers located next to
genes expressed during early embryonic neuroectoderm specialization (Tamagaki et al.
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2000; Pazmany and Tomasi 2006; Wang et al. 2008; Hamid and Brandt 2009; Mojsin
and Stevanovic 2009; Göhring et al. 2010; Xiang et al. 2010). D17S2180 and DXS1208
are related to endoderm and mesoderm specialization genes, respectively (Fu et al. 2003;
Wu et al. 2007; Lui et al. 2008; Kumarapeli et al. 2010; Schwarz et al. 2010) (Table 3.5).
In comparison to H7 ES cell unstable markers, D16S3091 is related to early mesoderm
gene differentiation, D1S468 is a gene that promotes apoptosis, and D12S1682 is both an
endoderm and mesoderm differentiation gene (Wechsler et al. 2002; Kim et al. 2007;
Sayan et al. 2010) (Table 3.5).
Third, genomic instability is a multistep process that involves genetic and
epigenetic modifications that induce opposite effects on the status of ES cell
pluripotency. Epigenetic changes such as chromatin assembly, imprinting, and
methylation are responsible for determining transcriptional patterns dependent upon the
cell stage. Imprinting is a switch for gene transcription that ensures cell proliferation,
development, and tissue specific functions (Kamakaka and Thomas 1990; Jaenisch and
Bird 2003; Dhara and Benvenisty 2004; Allegrucci et al. 2007; Kim et al. 2007; Shen et
al. 2008). Developmental genes for ES cells have a specific pattern of histone
modifications that determine the status of activation of specific genes involved in
embryonic development and cell fate during differentiation by de novo methylation. For
example, the OCT4 gene is unmethylated during pluripotency by bivalent histone
modifications to ensure cell proliferation and development. However, OCT4 is
completely repressed when cell differentiation occurs (Loh et al. 2006; Mikkelsen et al.
2007; Chamberlain et al. 2008). ES cell lines in vitro fail to maintain a specific epigenetic
pattern, inducing changes in the cellular status that leads to loss of ES cell pluripotency
over time (Bibikova et al. 2006; Allegrucci et al. 2007; Yu et al. 2007; Ahmed et al.
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2010). In our results, H1 and H7 ES cells showed significant differences of instability in
markers that were located next to chromatin assembly and imprinting genes across time.
Genomic instability was observed in markers such as D22447, D6S2252, HISTHB2, and
D10 S529, all of which were located close to genes that code for basic nuclear histone
proteins. Histones are proteins responsible for the octameric structure of the nucleosome;
they are formed by two molecules of each histone H2A, H2B, H3, and H4. The D6S2252
marker is located next to HIST1H2AH (linker histone H1), which interacts with the DNA
between nucleosomes and is responsible for chromatin compaction (Wang et al. 2004;
Zhang et al. 2005; Petty et al. 2009). D10S529 is a marker for a variant histone,
H2AFY2 that contributes to the inactivation of X chromosome (Chadwick and Willard
2001; Buschbeck et al. 2009; Gamble et al. 2010). In zebra fish embryos, it has been
observed that H2AFY2 is involved in the activation of neuronal differentiation genes
such as the homeobox A1 gene (HOXA), which encodes a DNA-binding transcription
factor to control gene expression during embryonic development and cell differentiation
(Buschbeck et al. 2009). D22S447 is a histone cell cycle regulator A (HIRA) that is a
homolog of Saccharomyces cerevisiae histone. HIRA is responsible for controlling cell
growth by regulation of cell cycle related genes (Ahmad et al. 2005). Taken together, our
results suggest that instability in these markers could be the signals that induce X
chromosome inactivation, ES cell growth, and differentiation through gene expression
changes in developmental and differentiation genes over multiple passages. Additionally,
imprinting markers also showed instability and are involved in the embryonic
methylation process. D2S144 is a marker for the DNA (cytosine-5-)-methyltransferase 3
alpha gene (DNMT3A) that is responsible for epigenetic modification of de novo DNA
methylation important for embryonic development, differentiation, imprinting, and X84

chromosome inactivation (Chen et al. 2002; Wienholz et al. 2010). Other unstable
markers are located next to the promoter region of imprinting genes, such as GRB10 and
IGF2, which are imprinted in a tissue specific manner. These results confirm that H1 and
H7 ES cells have a constant and actively regulated process across passages that control
genetic and epigenetic outcomes to ensure ES cell growth, maintenance of cell feature
characteristics or cell differentiation in vitro.
In conclusion, our findings indicate that maintenance of ES cell genetic and
epigenetic characteristics is compromised by the loss of DNA integrity in tandem repeat
sequences that flank specific genes that are responsible for the pluripotency and selfrenewal of ES cells maintenance, cell fate during differentiation, chromatin assembly,
imprinting, and methylation. From our data, we can support the idea that genomic
instability could be responsible for genetic and epigenetic imbalances originating in long
term ES cell cultures. The exact signals that coordinate this process are complex and not
completely known. Even so, our data support our hypothesis that instability in repetitive
sequences located close to specific genes could be the signal for adaptation or
differentiation of ES cells in culture passages over time.
Furthermore, our results give rise to the identification of biomarkers that could be
part of an ES cell characterization process that evaluates genomic integrity through in
vitro maintenance procedures. Understanding the role of genomic instability in ES cell
maintenance could lead to the origin of an accurate approach for the safety needed in
regenerative medical applications of human ES cells.
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Figure 3.1

Flowchart of H1 and H7 ES cell line maintenance in culture
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Figure 3.2

Examples of electropherograms

Notes: Examples of normal and mutated alleles of mononucleotide markers (GRB10PROM, IGF2-PROM, and HISTBH2) showing the corresponding normal allele as well as
the mutated allele that was shifted greater than 3 repeats or less than 3 repeats. Mutated
alleles are shown with a red star and the number of repeat shifts in parentheses. (-) means
a loss of repeat units, while (+) means a gain of repeat units. Each set of peaks is
identified by the marker name and repeat motif (top row). Shown below each peak is the
size of the allele in base pair (bp). Markers are labeled with either 6-FAM (blue) or HEX
(green) fluorescent dyes.
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Figure 3.2 Continued
Notes: Examples of normal and mutated alleles of dinucleotide markers (D18S63,
D6S2252, and D10S529) showing the corresponding normal allele as well as mutated
allele that was shifted greater than 2 repeats or less than 3 repeats. Mutated alleles are
shown with a red star and the number of repeat shifts in parentheses. (-) means a loss of
repeat units, while (+) means a gain of repeat units. Each set of peaks is identified by the
marker name and repeat motif (top row). Shown below each peak is the size of the allele
in base pair (bp). Markers are labeled with either 6-FAM (blue) or HEX (green)
fluorescent dyes.
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Figure 3.2 Continued
Notes: Examples of normal and mutated alleles of trinucleotide marker (D17S2180),
tetranucleotide markers (OCT4, and D1S551), and pentanucleotide marker (DIRAS3PROM) showing the corresponding normal allele as well as the mutated allele that were
shifted greater than 1 repeat or less than 2 repeats. Mutated alleles are shown with a red
star and the number of repeat shifts in parentheses. (-) means a loss of repeat units, while
(+) means a gain of repeat units. The markers D17S2180 and DIRAS-PROM only show
the normal allele because these markers were stable for the samples analyzed. Each set of
peaks is identified by the marker name and repeat motif (top row). Shown below each
peak is the base pair (bp) size of the allele in base pair (bp). Markers are labeled with
either 6-FAM (blue) or HEX (green) fluorescent dyes.

89

Figure 3.3

ES cell characterization

Notes: (A and B) H1 and H7 undifferentiated ES cells colonies, respectively. Colonies
show a condensed and multilayer pattern of growth over the mouse embryonic fibroblast
feeder layer (MEF) (Phase contrast photomicrographs with magnification 10X). (C)
Boxed region from B, shows in 60X magnification of multilayer colony and displays
typical H1 ES cells morphology in culture. The white arrows indicate ES cells with a
high nucleus to cytoplasm ratio. (D) Alkaline phosphatase positive H7 ES cells colony.
(E) H7 ES cells showing SSEA-1 positive expression (green). (F) ES cells showing
OCT4 positive expression (red). Nuclei were visualized with DAPI stain (blue).
Fluorescence photomicrographs are show with magnification of 60X.
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Figure 3.4

Morphologies of H1 ES cell colonies

Notes: (A) Phase contrast image shows an undifferentiated homogeneous colony. (B)
Phase contrast image shows heterogeneous colony morphology with differentiation at the
periphery of colony (white arrows). Phase contrast photomicrographs have a
magnification of 10X.
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p=0.04

p=0.047

Figure 3.5

Percentage of H1 and H7 ES colony morphology changes vs culture
passages

Notes: ES cells were subcultured/passaged approximately 20 times over 4 months by
mechanical dissection of the colonies. Throughout, ES cells failed to retain their normal
morphology. Values are the percentage of colonies with irregular morphology across
passages. The differences in morphology for colonies of ES cell lines were statistically
significant between H1 and H7 ES cell lines when compared to early (passages 27-28)
27
and middle (passages 40--42). Error bars, SD, p<0.05 (n=4).

92

Figure 3.6

Number of unstable markers across culture passages

Notes: H1 cells show statistically significant differences for frequencies of unstable
markers across passages in comparison to H7 cells (p<0.05). Values represent the number
of markers that show instability through the passages in each ES cell line. Early (passages
27-28), middle (passage 42), and late (passage 78-82).
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Figure 3.7

Unstable markers related to genes involved in pluripotency and early
differentiation

Notes: Differences in the number of unstable markers and mean mutation frequencies
were observed between H1 and H7 ES cell lines. (A) Shows the number of unstable
markers per ES cell line, and the cellular status of either pluripotency or differentiation.
(B) Mean values of mutation frequencies of unstable markers related to pluripotency
genes. (C) Mean values of mutation frequencies of unstable markers related to
differentiation genes. Values represent the mean value of mutation frequency of sample
replicates (n=48) per marker that was calculated with SP-PCR software (MD Anderson
Cancer Houston, TX). Statistically significance differences *p≤0.05, marginally
significance p≤0.10.
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Figure 3.8

Unstable markers related to chromatin assembly genes

Notes: Differences in the number of unstable markers and mean mutation frequencies
were observed between H1 and H7 ES cell lines. (A) Number of unstable markers per ES
cell line. (B) Mean values for mutation frequencies of unstable markers related to
chromatin assembly genes. Values represent the mean mutation frequency of sample
replicates (n=48) per marker calculated with SP-PCR software (MD Anderson Cancer
Houston, TX). HISTHB2 shows highly significant differences in mean mutation
frequencies of H7 ES cells (p <0.001). D10S529 shows instability in both ES cells lines,
but H7 ES cells show a significantly higher mutation frequency compared to H1 ES cells
(p = 0.03). Statistically significance *p<0.05.
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Figure 3.9

Unstable markers related to imprinting genes

Notes: Differences in the number of unstable markers and mean mutation frequencies
were observed between H1 and H7 ES cell lines. (A) Number of unstable markers per ES
cell line. (B) Mean values for mutation frequencies of unstable markers related to
imprinting genes. Values represent the mean mutation frequency of sample replicates
(n=48) per marker calculated with SP-PCR software (MD Anderson Cancer Houston,
TX). GRB10-PROM shows instability for both ES cell lines, but H1 ES cells show a
significantly higher mutation frequency compared to H7 ES cells (p = 0.026). Statistically
significance *p<0.05. Marginally significant differences **p <0.10.
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Table 3.1

List of single tandem repeat markers

Pluripotency
OCT4
D1S1656
D1S551
D12S1682
D1S2630
D6S2384
D6S416
D2S2327
kLF4-1
NANOG
D9S1840

Chromatin
Structure

Differentiation
D16S3034
D12S1719
D4S2623
D2S134
D11S1331
D4S1625
D1S430
D2S290
D3S1583
DXS458
D21S1909
D6S1698
D10S1653
D11S909
D5S2021
D18S63

D4S1542
DXS981
D14S588
D3S2459
D17S2180
EGFR
D16S3091
D1S468
TNFa3
D15S983
DXS1208
D5S426
D3S1541
G60405
D3S1611
D11S2179

D7S488
D6S1001
HISTH4A
HISTHB2
D10S529
D22S447
D8S11268
D22S941
D7S638
D6S2252
D2S144
DNMT3

Imprinting
GRB10PROM
D20S821
IGF2R
DIRAS3PROM
PEG10PROM
SNURF10PROM
IGF2PROM
IGF

Notes: Eleven markers were related to pluripotency genes, thirty-three were related to
differentiation genes, twelve were related to chromatin structure genes, and eight were
related to imprinting genes.
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Table 3.2

Mutation frequencies of five single tandem repeat markers located near genes related to pluripotency and
differentiation
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Notes: Number of normal alleles (n), number of mutated alleles (m), and mean value of mutation frequency (f) calculated by SPPCR software with SP-PCR software (MD Anderson Cancer Houston, TX). p-values ≤ 0.05 are in bold, p-value ≤ 0.10 in italic

Table 3.3

Mutation frequencies of three single tandem repeat markers located near genes related to chromatin assembly
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Notes: Number of normal alleles (n), number of mutated alleles (m), and mean value of mutation frequency (f) calculated by SPPCR software with SP-PCR software (MD Anderson Cancer Houston, TX). p-value ≤ 0.05 are in bold

Table 3.4

Mutation frequencies of three single tandem repeat markers located near genes related to imprinting genes
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Notes: Number of normal alleles (n), number of mutated alleles (m), and mean value of mutation frequency (f) calculated with SPPCR software (MD Anderson Cancer Houston, TX). p-values ≤ 0.05 are in bold, p-value ≤ 0.10 in italic

Table 3.5

List of unstable markers

Notes: Summary of characteristics of genes located in close proximity to unstable
markers involved in embryonic development. Twelve markers showed statistically
significant instability frequencies and are identified in bold (p<0.05).
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Table 3.5 continued
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CHAPTER IV
GENOMIC INSTABILITY DURING EARLY DIFFERENTIATION OF EMBRYONIC
STEM CELLS
4.1

Abstract
Understanding how genomic instability could be involved in the regulation and

establishment of cell lineage commitment during embryonic stem (ES) cell differentiation
into an embryoid body (EB) would provide crucial knowledge of stem cell biology.
Therefore, defining the signaling pathway that controls early cell fate decisions is an
important focus of research. Here, we determine the degree of instability in single tandem
repeat markers located near embryonic developmental genes responsible for pluripotency,
differentiation, and imprinting of the ES cells. We determined that the mean values of
instability frequencies in EB from H1 and H7 ES cell lines showed significant differences
across time between ES cell lines. Markers that became unstable during spontaneous
differentiation showed higher instability frequencies associated with pluripotency
(D1S551), differentiation (D16S3034, D16S3090, D14S588, D11S4090, D3S1583,
D1S468, DXS1208, D4S2623, and D18S63), and imprinting (IGF2PROM,
GRB10PROM, HISTHB2, D6S2252, D2S144, D3S1611, D7S488, and D10S529).
Genomic instability influences the loss of pluripotency and the gain of cell lineage
specialization. Interestingly, the differentiation potential of EBs from the two stem cell
lines varied. EBs from H1 were prone to neuroectoderm differentiation in comparison to
EBs from H7, which showed functional differentiation into mesoderm in the form of
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contractile cardiac muscle. We suggest that genomic instability in repetitive regions could
be a signal for cell fate decision during differentiation among ES cell lines. Our results
indicate correlation of instability in specific markers located near developmental genes
and epigenetic modulators in EB that underwent spontaneous differentiation in vitro. The
significance of elucidating possible molecular mechanisms of genomic instability and
validation of novel biomarkers could potentially lead to use of ES cell derivatives are safe
source for cell tissue replacement in clinical applications.
4.2

Introduction
ES cells are derived from the inner cell mass of a blastocyst after the first

differentiation stage during embryonic development. During this stage, the embryo loses
totipotency and displays pluripotent characteristics that ensure its potential for
differentiation into the three germinal cell layers (Thomson et al. 1998; Chen et al. 2008).
ES cells can differentiate into all cell types of the embryo by spontaneous differentiation
in vitro into EBs. Colonies of ES cells can be cultured in suspension with conventional
ES cell culture techniques in a medium supplemented with serum containing many
undefined growth factors that induce differentiation into EB. Differentiation into EB is
spontaneous process that always displays a heterogeneous mix of cell populations and is
a technique to demonstrate the pluripotency capacity of the ES cells to differentiate into
all three germinal layers (Thomson et al. 1998; Enver et al. 2005). However, these
protocols are inappropriate for obtaining large numbers of homogeneous and pure cell
type populations that are needed for cell regeneration treatments of human diseases.
Conditions for culture establishment and maintenance are a constant scientific
challenge to improve the methodology used for this therapeutic aim. Determination and
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validation of precise growth factors that direction of ES cell specialization towards a
homogeneous population of a selected germinal layer such as ectoderm for neurons,
endoderm for pancreatic cells, or mesoderm for cardiac muscle cells still is a work in
progress. Several approaches have been reported for supplementing media with specific
exogenous growth factors that direct ES cell differentiation to induce mature specialized
cell types, such as noggin factor that induces neural lineage commitment, activin A that
induces definitive endoderm, and bone morphogenic protein (BMP) plus activin A that
induce mesoderm differentiation into early cardiac muscle cells (Ben-Hur et al. 2004;
D'Amour et al. 2006; Yao et al. 2006; Jiang et al. 2007; Yang et al. 2008; Zhou et al.
2008).
Differentiation is a constant process of gene modification and chromatin
regulation that is responsible for the specific signals that induce morphological and
functional changes in early cell progenitor derivatives during embryonic development
(Niwa et al. 2005). Differentiation reflects the alteration of balance between ES cell
pluripotency and self-renewal. ES cells that differentiate lose pluripotency and gain the
lineage-specific signature that displays specific cell tissue identity through gene and
chromatin modification in the promoter regions of developmental genes responsible for
pluripotency and early cell differentiation (Mohn et al. 2008). Identification of the
molecular switches that regulate differentiation of early cell progenitors could be used as
a tool for target ES cell pluripotency and achieve differentiation homeostasis.
Pluripotency, self-renewal, and differentiation signals in ES cells naturally occur
as a result of extracellular environmental stimuli. Regulation of these specific cellular
signals during ES cell maintenance in vitro contributes to correct cell fate decisions
(Niwa 2007). Genetic and environmental changes influence the phenotype of the ES cell
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lines. It is important to fully characterize ES cell lines for comparative analyses in order
to completely define their identity. Precise and well standardized biomarkers are needed
to characterize ES cells at molecular and functional levels to ensure their quality and
efficiency for cellular transplant and organ regeneration applications. In addition, this
will be a crucial tool for basic embryonic development, drug testing, toxicology, and
tumorigenesis research.
Several studies reported successful EB formation from ES cell lines through
spontaneous differentiation into the three germinal layers. Gene expression and
epigenetic pattern characteristics that underline differentiation of ES cell lines in vitro
have been widely reported (Brimble et al. 2004; Ware et al. 2006; Adewumi et al. 2007;
Allegrucci et al. 2007; Osafune et al. 2008). However, the precise molecular signals that
coordinate ES cell differentiation are not understood. Identification of unstable repetitive
sequences of the DNA is a sensitive molecular technique to evaluate DNA integrity of ES
cells. ES cells in culture acquire different genetic and epigenetic modifications in order to
maintain pluripotency or induce ES cell differentiation into the functional phenotype of
lineage specific neuroectoderm, mesoderm, or endoderm cell layers (Enver et al. 2005;
Allegrucci et al. 2007; Baker et al. 2007).
We determined genomic instability during spontaneous differentiation of EB from
H1 and H7 ES cell lines. EB samples were obtained at three time points of EB
progression at 7, 14, and 30 days after differentiation induction. The frequency of
genomic instability in 63 single tandem repeat markers located near pluripotency,
differentiation, and imprinting genes was determinate by calculating the instability
frequency of each sample per marker. The aim of this study was to determine novel
molecular biomarkers for monitoring ES cell signals that govern differentiation in vitro.
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We report that genomic instability could be the signal that leads to ES cell differentiation
through modulation of gene expression and epigenetic modifications during cell lineage
and tissue derivation of cell populations in EBs from H1 and H7 ES cell lines. Finally,
determination of reported single tandem repeat stability offers a mechanism for
characterization as well as defining new protocols for directing ES cell differentiation in
vitro towards particular cell lineages that are needed for clinical applications
4.3
4.3.1

Materials and Methods
Embryonic stem cell culture conditions
Frozen aliquots from human ES cells H1-WA01 passage 27 and H7-WA07

passage 26 were purchased from the National Stem Cell Bank – Wisconsin International
Stem Cell Bank (Appendix B). H1 and H7 ES cells were seeded onto a mouse embryo
fibroblast-CF1 (MEF) feeder layer previously inactivated with mitomicyn C. The culture
medium consisted of Dulbecco’s Modified Eagle Medium (DMEM) knockout medium
(Invitrogen, Carlsbad, CA) supplemented with 10% knockout serum replacement
(Invitrogen, Carlsbad, CA), 1% antibiotic-antimycotic (Invitrogen, Carlsbad, CA), 100
µM β-mercaptoethanol (Sigma Aldrich Saint Louis, MO), 20 ng/ml basic fibroblast
growth factor (b-FGF) (Invitrogen, Carlsbad, CA ), 1% non-essential amino acids
(Invitrogen Carlsbad, CA), 2 nM L-glutamine (Invitrogen, Carlsbad, CA), and 20 ng/ml
of Leukemia Inhibitor Factor (LIF) (Chemicon/Millipore Billerica, MA). ES cells were
maintained in a humidified atmosphere at 37°C in 5% CO2. The medium was changed
daily.
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4.3.2

Embryoid body formation
For in vitro differentiation of ES cells through embryoid body formation,

undifferentiated ES cell colonies at 3-5 days post-passage, maintained on a mouse
embryo fibroblast (MEF) feeder layer during 15 passages for both ES cell lines, were
mechanically dissociated and transferred into a low attachment petri dish containing
embryoid body (EB) medium. EB medium consisted of Dulbecco’s Modified Eagle
Medium (DMEM) knockout medium (Invitrogen, Carlsbad, CA) supplemented with 20%
fetal calf serum (Invitrogen, Carlsbad, CA), 1% L-glutamine (Invitrogen, Carlsbad, CA),
1% non essential amino acids (NEAA) (Invitrogen, Carlsbad, CA), and 0.1 mM βmercaptoethanol (Sigma, Aldrich Saint Louis, MO). EBs were cultured in suspension for
5 days with medium changes every other day. Then, EBs were transferred to 60 mm
center-well culture dishes (Corning Incorporated, Corning, NY) previously coated with
0.1% gelatin (Sigma, Aldrich Saint Louis, MO) and cultured for 30 days with EBmedium in a humidified atmosphere at 37°C and 5% CO2. During the 30 day culture
period, medium was renewed every 2 days, but less frequent medium changes were made
depending on EB culture density. Samples of EBs in culture were collected at 7, 14, and
30 days for histopathology, immunohistochemical, and molecular analysis.
4.3.3

Histopathology
EBs were harvested and fixed with formalin (Sigma-Aldrich, Saint Louis, MO)

overnight at room temperature, washed in 1X PBS, dehydrated with an ethanol wash, and
embedded in paraffin. The five micrometer thick sections from the paraffin embedded
EBs were placed on slides. After deparaffinization of the slide by xylene, alcohol, and
water washes, slides were stained with hematoxylin-eosin for routine histological
examination under microscope.
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4.3.4

Immunohistochemical analysis
EB samples attached to gelatin were fixed with 4% paraformaldehyde (Sigma-

Aldrich, Saint Louis, MO) for 15 minutes at room temperature, washed in 1X PBS, and
immunostained (Miltenyi Biotec Inc, Auburn, CA). The primary antibodies used were
rabbit anti-GATA4 polyclonal antibody (endoderm), anti-myosin heavy chain
monoclonal antibody (mesoderm), and anti- β-III Tubulin clone AA2 alexa fluor 488
conjugated mouse monoclonal antibody (ectoderm) (Chemicon/Millipore Billerica, MA).
Antigen detection was performed with secondary antibodies; goat-anti-rabbit IgG
rhodamine and C5Y conjugated secondary antibody (Chemicon/Millipore Billerica, MA).
Each antibody was diluted to 1:200 in 1X PBS with 0.1% Triton X-100 and 3% BSA.
Nuclei were visualized with 4’-6-diamidino-2-phenylindole (DAPI) staining (Vysis
Abbott Laboratories, Abbott Park, IL). EBs stained without the primary antibody served
as a negative control. Images were captured using a fluorescence microscope, Axiovert
135, (Carl Zeiss International), with a FITC and Rhodamine filter set. Fluorescent
intensities were measured with a semi quantitative method using image software
developed at the National Institute of Health (Bethesda, MD, USA). Software was
downloaded from http://rsb.info.nih.gov/ij/index.html. Accumulation of fluorescence was
calculated by averaging the fluorescent ratio between exposed and unexposed areas in the
nuclei.
4.3.5

Germinal layer separation from embryoid bodies
After 30 days in differentiation culture, EBs were harvested using 0.5 mg/ml

collagenase D (Sigma Aldrich, Saint Louis, MO) in DMEM for 5 minutes at 37°C and
pipetting to obtain a single cell suspension. EBs were washed twice with 1X PBS.
Suspensions of cells were separated by positive selection with the Mini-MAC system cell
119

separation into three different types of cell populations (Miltenyi Biotec Inc,
Auburn,CA). Ectoderm cells were magnetically labeled with Anti-PSA-NCAM
microbeads, mesoderm cells with CD56 microbeads, and endoderm cells with CD326
(EpCAM) microbeads (Miltenyi Biotec Inc, Auburn, CA). Cells from each specific
separation (ectoderm, mesoderm, and endoderm) were collected for DNA isolation and
molecular analysis.
4.3.6

DNA isolation
DNA was prepared from each sample of EBs (7, 14, 30 days of differentiation

induction) that were previously collected in 1X PBS by mechanical disruption in pieces
under a stereomicroscope. Samples from EBs and cell suspensions were isolated with the
Purelink™ genomic DNA mini-kit (Invitrogen Carlsbad, CA) following the
manufacturer’s protocol. All DNA samples were quantified using a NanoDrop™
ND1000 spectrophotometer (Thermo Scientific, Wilmington, DE).
4.3.7

Determination of genomic instability with single cell PCR
Analysis of genomic instability of all DNA samples (listed previously) was

carried out using 63 STR markers. Eleven markers were located near promoters of
pluripotency genes, thirty-two markers were related to differentiation genes, and twenty
markers were related to imprinting genes (Table 4.1). Total reaction volume of
fluorescent multiplex PCR reactions was 10µl containing 1X of 10X buffer D, 2.5 mM of
MgCl2, 1.25 U of Hot-MultiTaq DNA polymerase, 1X of Solution L (these four reagents
are from US DNA, Fort Worth, TX), 4% of DMSO (Sigma Aldrich, Saint Louis, MO),
0.4 mg/ml of BSA (Thermo Scientific, Rockford, IL), 300 µM of dNTPs (Applied
Biosystems, Foster City, CA), and primer sets at a final concentration ranging between
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0.2-2 µM (Table 2.2 in CHAPTER II). Each replicate contained 9 µl of master mix with
1µl of DNA at a concentration of less than a single diploid genome-equivalent (25-50
pg/µl). This DNA concentration allowed detection of wild type and mutant alleles in the
same replicate (Coolbaugh-Murphy et al. 2004). Forty eight replicates for each marker
and each sample with appropriate negative controls were amplified. PCR was performed
on a PE 9600 thermocycler using a ramping protocol: 1 cycle of 95°C for 11 minutes; 1
cycle of 96°C for 1 minute; 10 cycles of [94°C for 30 seconds, ramp 68 seconds to 58°C
(hold for 30 seconds), ramp 50 seconds to 70°C (hold for 60 seconds)]; 25 cycles of
[90°C for 30 seconds, ramp 60 seconds to 58°C (hold for 30 seconds), ramp 50 seconds to
70°C (hold for 60 seconds)]; 1 cycle of 60°C for 30 minutes for final extension for
adenine addition; and hold 4°C. Negative controls without DNA were included to check
for contamination.
Fluorescent PCR products (0.5 µl) were denatured in formamide (4.35 µl)
(Applied Biosystemss, Foster City, CA) and size standard Genescan 500-LIZ (0.15 µl)
(Applied Biosystemss, Foster City, CA), to be detected by capillary electrophoresis on an
AB3130xl Genetic Analyzer (Applied Biosystemss, Foster City, CA). Fragment size of
alleles was estimated by GeneMapper software version 4.0 (Applied Biosystemss Foster
City, CA). Wild type and mutated alleles of each marker were quantified according to
standardization explained in the Materials and Methods section 3.3.7 in CHAPTER III.
Examples of normal and mutated alleles per markers are shown in Figure 4.1.
4.3.8

Statistical analysis of genomic instability
Mutation frequencies were determined using SP-PCR software version 1.0 (M.D.

Anderson Cancer Center Houston, TX) (Appendix C). Differences in mutation
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frequencies were calculated with a two tailed t-test using raw mutation frequencies in the
statistical package SAS/win 9.2 (SAS Institute, Cary, NC) to determine statistically
significant differences (p-value ≤0.05) in the mean mutation frequencies of informative
markers. Marginally significant differences were considered if the p value was ≤0.10.
4.4
4.4.1

Results
ES cells spontaneously differentiate into embryoid bodies in vitro
ES cell pluripotency is evaluated by the efficiency with which they form EBs and

drive ES cell differentiation into the three germinal layers symmetrically and
spontaneously upon removal of leukemia inhibitor factor (LIF) and the MEF feeder layer,
and supplementing of the medium with 20% fetal calf-serum (Chambers et al. 2003;
D'Amour et al. 2006). Initially, our EBs developed compact and tri-dimensional cell
aggregates in suspension during the first 7 days. Once they attached, EB aggregates
began to spread and display an irregular shape distribution. This was indicative of
differentiation into a heterogeneous mix of cell populations derived from the three
germinal layers from day 7 to day 30 after induction of EB differentiation. Microscopic
morphology of EBs was determined with stained paraffin-embedded sections. The EB
morphology showed stratified keratinizing epithelium (characteristic of ectoderm),
cardiac muscle (characteristic of mesoderm), and pseudostratified columnar epithelium
(characteristic of endoderm) (Figure 4.2). The morphology, coupled with the expression
of specific immunofluorescence markers (β-III tubulin-ectoderm, Myosin-mesoderm, and
GATA4-endoderm), confirmed that H1 and H7 ES cell lines maintained the capacity for
spontaneous differentiation into EBs that display a mixed population of cells from the
three germinal layers during in vitro culturing (Figure 4.3).
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4.4.2

Genomic instability is present during ES cells differentiation in vitro
During early determination of cell fate, genes responsible for cell differentiation

are activated and pluripotency genes are turned off. The molecular mechanisms that
induce these gene expression changes are unclear (Boyer et al. 2005). The aim of this
study was to determine if genomic instability was present at this time and could possibly
be a signal of ES cells’ spontaneous differentiation. ES cells that efficiently differentiate
into EBs were evaluated for genomic instability with 63 single tandem repeat markers
located near genes involved in pluripotency, differentiation, and imprinting (Table 4.1).
DNA from H1 and H7 EBs at three time points (7, 14, and 30 days) after culture
establishment were analyzed. Significant mean frequencies of instability in 18 out of 63
markers were detected. Markers located near differentiation and imprinting genes
displayed higher instability frequencies compared to markers located near pluripotency
genes. Only one marker located near a pluripotency gene showed significant instability
(D1S551). In comparison, nine markers located near differentiation genes were
significantly unstable (D16S3034, D16S3090, D14S588, D11S4090, D3S1583, D1S468,
DXS1208, D4S2623, and D18S63), and eight markers related to imprinting were
significantly unstable (IGF2PROM, GRB10PROM, HISTHB2, D6S2252, D2S144,
D3S1611, D7S488, and D10S529). These results show that genomic instability was
detected in specific single tandem repeat markers during EB differentiation and could be
determinate signals for ES cell fate specialization.
4.4.3

Single tandem repeat instability increased during EB formation over time
ES cell differentiation occurs in a spontaneous multistep manner, which results in

cell specialization. We found significant differences in genomic instability among EBs
from H1 and H7 ES cell lines over time. At 30 days post differentiation, EB samples
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were significantly unstable in comparison to EBs from 7 and 14 days. Instability
frequencies at day 30 were increased two-fold in comparison with the earlier frequencies
(day 7). EBs from H1 showed an instability mutation frequency of 0.018 at 7 days and
0.039 at 30 days, whereas EBs from the H7 showed an instability frequency of 0.016 at 7
days and 0.036 at 30 days (p<0.05) (Figure 4.4). EBs from H1 show an increased number
of unstable markers (n=18) time in comparison to EBs from H7 (n=14). HISTHB2,
IGF2PROM, and D3S1583 were unstable markers at 7 days of EB culture. In contrast,
markers that were unstable at 14 days included D18S63, D3S1611, D6S2252, HISTHB2,
D16S3034, and D3S1583. At 30 days unstable markers: D1S468, DXS1208, D2S144,
GRB10PROM, D7S488, D4S2623, D10S529, D16S3090, IGF2PROM, D11S4090, and
D14S588 (Figure 4.4). These observations confirmed that spontaneous differentiation
occurred at the same time that genomic instability increased during EB formation.
Therefore, genomic instability could potentially drive differentiation progression in vitro.
4.4.4

Embryoid bodies from H1 and H7 ES cell lines show different unstable
marker profiles
During the last decade, complete gene expression profiles have been reported for

ES cells. Gene expression modifications are due to ES cell culture maintenance in vitro
(Boyer et al. 2005; Loh et al. 2006). The aim of this study was to determining whether
EBs from H1 and H7 ES cell lines would show instability in the same markers. Our study
reports that eight markers showed increased instability in markers for EBs of both ES cell
lines (D16S3034, D10S529, D14S588, D16S3091, IGF2PROM, D11S4090, D3S1583,
and D1S551) (Figure 4.5 and Table 4.2). EBs from H1 showed the highest significant
mean frequencies of instability in seven additional markers (D1S468, DXS1208,
D2S144, GRB10PROM, D18S563, D3S1611, and D7S488) (p≤0.05) (Figure 4.6 and
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Table 4.3) whereas, EBs from H7 showed instability in only three additional markers
(HISTHB2, D6S2252, and D4S2623) (p≤0.05) (Figure 4.6 and Table 4.4). Notably,
unstable markers in EB from H1 were located near genes involved in early
neuroectodermal differentiation. In contrast, EBs from H7 displayed instability in
markers located near genes involved in mesodermal and endodermal differentiation. EBs
from both H1 and H7 ES cell lines showed instability in markers related to imprinting
genes. Taken together these results confirm that ES cells showed differential profiles of
unstable markers during EB differentiation in vitro.
4.4.5

Instability in repetitive regions related to differentiation genes coordinate
cell fate decisions
Upon progression of differentiation, gene modifications act as signals that

facilitate cell fate decisions (Smith 2005; Feldman et al. 2006; Galán et al. 2010). We
searched for possible associations between genomic instability of specific markers and
the differentiation preferences of individual ES cell lines. We characterized our ES cell
lines by morphologic and genomic instability patterns throughout EB differentiation in
vitro. EBs from H1 and H7 ES cell lines showed mixed populations of cells after 30 days
of culturing in EB media supplemented with fetal calf serum. However, we observed that
multiple neural rosette like neuroectoderm structures were more common in EB cultures
from H1 when compared to EBs from H7 (Figure 4.7). This is positively correlated with
instances of instability that showed increased mean frequencies for markers specific to
the neuroectoderm layer (D11S4090, D3S1583, D1S468, DXS1208, and D18S63). In
contrast, EBs from H7 showed instability in markers related to mesoderm (D14S588 and
D16S3091) (Boie et al. 1995; Li et al. 2010), and endoderm differentiation (D4S2623)
(Chu and Shen 2010) (Table 3.5). In addition, EBs from H7 showed morphological and
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functional spontaneous differentiation into contracting EBs, increased cell confluency, as
well as increased contraction rates in the developing EBs (Figure 4.8). Our results show
that instability in repetitive regions near genes responsible for early cell differentiation of
neuroectoderm and mesoderm were not equally regulated between differentiation of H1
and H7 ES cell lines in vitro.
4.4.6

Epigenetic modification during spontaneous EB differentiation a result
from genomic instability
Early embryonic differentiation signals are regulated by epigenetic changes such

as imprinting, chromatin changes, and methylation (Lee et al. 2006; Pasini et al. 2007;
Christophersen and Helin 2010). We found that specific markers related to imprinting
showed increased frequencies of instability during EB differentiation from both ES cell
lines. Markers associated with tissue specific imprinting genes (IGF2, and GRB10),
histone genes (HISTHB2, D6S2252, D7S488, and D10S529), de novo methylation genes
(D2S144), and DNA repair genes (D3S1611) showed significant differences in instability
in EB from H1 and H7 ES cell lines. Markers located in the promoter regions of the
genes IGF2 and GRB10 displayed highly significant instability (p<0.001). The marker
near IGF2 was unstable in EBs from both the H1 and H7, with the highest instability
frequency found in EBs from the H7. The marker in GRB10 however, was exclusively
unstable in EBs from the H1. Additionally, D2S144 was significantly, and exclusively,
unstable in EBs from H1 (p=0.0081) compared with EBs from the H7 that were stable.
D10S529 was unstable in EBs from both ES cell lines but was highly significantly
unstable in EBs from the H1 compared with EB from H7 (p=0.0308). Together, these
findings demonstrate that instability as a molecular signaling pathway might control the
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epigenetic changes necessary to induce gene expression changes in ES cells that are
undergoing early progenitor differentiation.
4.5

Discussion
Understanding the molecular signals that regulate the decisions determining ES

cell fates in vitro during early progenitor differentiation can help identify reliable genetic
markers that will be useful for characterizing the mix of cell populations obtained from
the three germinal layers. Careful characterization of ES cells and their cell-type specific
outcomes serve to validate them for prospective clinical applications that would require
specific ES cell progenies isolated from spontaneous differentiation protocols in vitro.
We evaluated single tandem repeat markers located near embryonic developmental genes
related to pluripotency, differentiation, and imprinting of ES cells, to determine their
stability during spontaneous differentiation of EBs in vitro.
Normally, ES cells can differentiate into a heterogeneous mixed population of EB
cell types from the three germinal layers in vitro. EBs can be differentiated into a wide
variety of cell types that are functionally equivalent to in vivo tissues (Chambers et al.
2003; D'Amour et al. 2006). We hypothesized that instability in repetitive sequences
located near important genes responsible for cell differentiation could control the
subsequent cell fate decisions during the progression of differentiation.
Differentiation is a process where pluripotency of the ES cells is lost through
embryogenesis. ES cells differentiate progressively until they achieve complete cell
specialization and functional cell-tissue capacities (Feldman et al. 2006; Galán et al.
2010). Our results show that EBs undergoing differentiation accumulates instability in
different markers located near possible target genes that are responsible for early cell
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differentiation and imprinting. This is consistent with our results that just one
pluripotency marker was unstable in comparison with nine unstable markers related to
differentiation, and eight unstable markers related to imprinting during EB culturing. This
is in contrast, our findings that. Our data suggest that some pluripotency genes still act
upon progression of differentiation until complete cell lineage commitment is achieved.
In addition, the observation of progressive instability in markers located near
differentiation and imprinting genes could be the signals of specific cell fate decisions
that are required for each ES cell line.
First, ES cells undergoing differentiation need intracellular and extracellular
signals that vary over time that regulate the transcriptional factor machinery. This induces
cell type specific changes through completion of lineage commitment (Snykers et al.
2007; Chowdhury et al. 2010). Extracellular signals, such as stress from the culture
environment and continual passaging, might affect the stability of ES cells undergoing
differentiation. The efficiency to further direct homogeneous differentiation is also
reduced because of subsequent losses in genomic integrity and changes in gene
expression (Vallier et al. 2005). Additionally, differentiation efficiency depends on the
level of cell confluency (Snykers et al. 2007). During differentiation induction in vitro,
our EBs showed increased cell density after 20 days in culture. We observed high
instability frequencies in EB samples at 30 days of culture. At that time, maximum
efficiency in cell to cell interaction and cell differentiation was observed, and the
confluence of EBs from H1 and H7 ES cell lines was almost 100%. Our data support the
affirmation that differentiation is a dynamic process where interaction between cells and
addition of chemical supplements to the culture medium can drive ES cells toward
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differentiation in addition to playing an important role in inducing molecular signals
needed to obtain specialized cell types.
Second, developmental genes are responsible for controlling differentiation in ES
cells. Molecular markers located near specific genes could be good candidates for the
evaluation of cell fate progression during embryogenesis. We found significant instability
frequencies in 18 single tandem repeat markers localized near developmental genes. Our
results support the idea that these markers are possible target sequences responsible for
the molecular signals of pluripotency, differentiation, and imprinting during ES cell
commitment specialization of lineage in vitro (Table 4.5). We found important
correlations between genes in close proximity to the unstable markers analyzed in this
study. For example, POU family transcription factor (POUF) is a regulator of
pluripotency that prevents ES cell differentiation. Repression of this gene induces ES cell
differentiation into primitive endoderm (Niwa et al. 2005; Feldman et al. 2006). D1S551
is a marker located near the POUF gene and was significantly unstable later in the EB
formation process (30 day sample), indicating that instability acts as a signal to silence
this pluripotency gene, and allows progression of differentiation of the ES cells. On the
other hand, genomic instability in repetitive regions could be required for selective
preference of differentiation into the three germinal layers during EB progression in H1
and H7 ES cells. In our study, signaling pathways that control spontaneous EB
differentiation in H1 and H7 in vitro reveal differences in the capacity to achieve
homogeneous cell populations at the end of differentiation. EBs from H1 and H7 did not
differentiate equally well into the three germinal layers. EBs from H1 efficiently
promoted more neuroectoderm structures in comparison to EBs from H7 that efficiently
promoted more mesoderm structures as a functional cardiac muscle cells. Our
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observations suggest that H1 and H7 ES cell lines show specific embryonic
differentiation patterns. Interestingly, EBs from H1 and H7 show different molecular
patterns of instability. Significant differences within unstable markers were observed and
could be the source of differences in the noted cell morphological and functional
characteristics. EBs from H1 were unstable for markers related to early neuroectoderm
differentiation. For example, D1S468 is located near tumor protein p53 (TP73) gene,
which is involved in the cellular stress response and development. Deletion of this gene is
involved in neuroblastoma (Berna S, 2010; Kim KP, 2007). DXS1208 is located near the
heat shock 27 kDa protein β1 (HSP25/27) gene implicated in astrocytic and cortical
degeneration (Schwarz et al. 2010; Kirbach and Golenhofen 2011). D18S63 is located
near the TGFβ-induced factor homeobox 1 (TGIF1), a transcription regulator during
development, and is associated with structural brain abnormalities (Pazmany and Tomasi
2006; Wang et al. 2008; Hamid and Brandt 2009). D11S4090 is located near the gene
neural cell adhesion molecule 1 (NCAM) that is necessary for the induction of synaptic
plasticity in the hippocampus (Kleene et al. 2010). D3S1583 is located near the retinoic
acid receptor beta (RARB) gene, which is a developmental gene responsible for cell
growth and differentiation (Sheng et al. 2010; Elizalde et al. 2011). Additionally, EBs
from H1 and H7 ES cell lines showed instability in markers involved in mesoderm
differentiation. For example, D16S3034 is located near the chromodomain helicase DNA
binding protein 9 (CHD9) gene that is involved in early osteogenic cell differentiation
(Shur et al. 2006). D16S3091 is located near cadherin 13 H-cadherin (CDH13) gene that
is a mediator of cell-cell interaction in the heart and negative regulator of neural cell
growth (Li et al. 2010).
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Third, epigenetic modifications are necessary to induce gene expression changes
in ES cells undergoing differentiation into early progenitor cell types of the three
germinal layers (ectoderm, endoderm, and mesoderm). Chromatin modification is a
mechanism that potentially drives cell fate decisions, cell renewal, and lineage
specialization. Improper silencing or activation of specific genes induces chromatin
remodeling modifications (Boyer et al. 2005; Enver et al. 2005; Feldman et al. 2006;
Baker et al. 2007). Changes in chromatin structure can regulate commitment
specialization of ES cell lineage by modulating gene expression through two ways: first,
by modification of histones and second, by methylation of promoters regulating specific
developmental genes. These modifications ensure the expression or repression of target
genes during cell differentiation. However, it is not fully understood how these steps are
coordinated. Previous studies have confirmed that histone modifications are associated
with transcriptionally active regions in the genome that regulate spontaneous
differentiation of ES cells in vitro (Boyer et al. 2005; Azuara 2006). ES cells that failed
to keep their repressive chromatin and lost the capacity to differentiate into the three
germinal layers (Enver et al. 2005; Pasini et al. 2007). Consequently, histone H2A
ubiquitination reduction and histone H3 and H4 acetylation enrichement modifications
allow gene transcription to maintain ES cell pluripotency (de Napoles et al. 2004; Lee et
al. 2006). Our results suggest that instability in repetitive regions near histone specific
genes could be a signal for histone modification that generates repressive or active
chromatin to modulate gene expression during cell lineage commitment. From our
results, four significant unstable markers that showed high instability are related to the
histone genes HISTHB2 and D6S2252 (HIST1H2AH), both of which are linker histones
responsible for chromatin compaction (Wang et al. 2004; Zhang et al. 2005; Petty et al.
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2009). Another histone gene, D10S529 (H2AFY2), is involved in inactivation of the X
chromosome (Buschbeck et al. 2009; Gamble et al. 2010). All three markers were
especially significant in the instability detected in EBs from H7 ES cell line when
compared to EBs from H1. Studies have reported changes in X inactivation in female ES
cells, which was congruent with our results because the H7 ES cell line is female
(Chadwick and Willard 2001; Buschbeck et al. 2009; Gamble et al. 2010). Marker
D7S488 located near the histone deacetylase 9 isoform 3 (HDAC) gene is responsible for
tissue-specific gene expression during cell differentiation (Karamboulas et al. 2006). We
found that this marker was exclusively unstable in EBs from H1. Taken together, our
results suggest that instability in these sequences, which are near specific histone genes,
could be a signal for chromatin modifications that repress expression of pluripotency
genes during spontaneous differentiation.
In addition to chromatin modification by histones, methylation of gene promoter
regions is responsible for establishing the epigenetic changes that allow for the
pluripotency or differentiation status of ES cells. DNA (cytosine-5)-methyltransferases
(DNMT) catalyze the addition of methyl groups to the cytosines in CpG islands that are
located in promoter regions of genes, and they are responsible for controlling access of
transcription factors to the genome (Jaenisch and Bird 2003). Changes in methylation
during differentiation have been widely reported (Lagarkova et al. 2006; Meissner et al.
2008), supporting the idea that methylation is a key gene regulator of the pathway leading
to ES cell fate decisions. D2S144 is located near the DNA (cytosine-5)-methyltransferase
3 alpha gene (DNMT3A) responsible for de novo DNA methylation during embryonic
development, and displays significant instability (Chen et al. 2002; Wienholz et al.
2010). DNMT3A de novo methylation in ES cell lines induces silencing in pluripotency
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and self-renewal genes in the differentiated cells and prevents de-differentiation or
reactivation of pluripotency in somatic adult tissues (Lagarkova et al. 2006). Methylation
is the mechanism for gene imprinting during early embryonic development. We also
observed significant unstable markers located in promoter regions of two genes that are
imprinted in tissue specific manner. Growth factor receptor-bound protein 10 (GRB10)
gene is imprinted in the paternal allele in the brain and is responsible for modulation of
tyrosine kinase activity. GRB10 overexpression results in suppression of embryonic
growth (Tezuka et al. 2007; Monk et al. 2009). Insulin-like growth factor 2 (IGF2) gene,
expressed only from the paternal allele, is involved in embryonic development and
growth (Demars et al. 2010; Tabano et al. 2010). Therefore, epigenetic modifications
have two essential functions, regulating cell fate decisions during stages of differentiation
and preserving the cell specialization status throughout the cell’s life.
Finally, identification of specific target sequences that are predominantly unstable
during spontaneous differentiation might provide clues to deciphering molecular
mechanisms used to express and/or repress genes during embryogenesis and cell lineage
commitment. In addition, our results reveal a novel molecular tool for characterizing cell
populations according to their genomic integrity through analysis of unstable markers
located near important genes responsible for early cell differentiation. This novel tool has
potential significance and practical applications for use in regenerative medicine. To our
knowledge, this study is the first to identify potentially useful biomarkers that can
determine the stability of specialized cell populations differentiated in vitro from ES
cells. Further evaluation of these markers will enable more precise characterizations of
ES cells and cell populations during development, so their applications could be fully
assessed.
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Figure 4.1

Examples of electropherograms from mononucleotide unstable markers.
markers

Notes: Normal and mutated alleles are identified according to repeat motif shifts.
Mononucleotide markers (IGF2
(IGF2-PROM, GRB10-PROM,
PROM, and HISTBH2) show the
corresponding normal allele, as well as the mutated allele that was shifted greater than 3
or less than 3 repeats motifs. Mutated alleles are indicated with a red star and the number
of repeat motif shifts is in parentheses. ((-)) indicated a loss of repeat units, while (+)
indicated a gain of repeat units. Normal alleles are shown next to their mutated alleles.
Each set of peaks is identified by the marker name and repeat motif (top row). Shown
below each peak is the size of each allele in base pair (bp). Markers were labeled with
either 6-FAM
FAM (blue) or HEX (green) fluorescent dyes.
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Figure 4.1 Continued.
Notes: Normal and mutated alleles are identified according to repeat motif shifts.
Dinucleotide markers (D1S468, D2S144, D3S1611, D13S1583, D6S2252, and D7S488)
show the corresponding normal allele, as well as the mutated allele that was shifted
greater than 2 or less than 3 repeat motifs. Mutated alleles are indicated with a red star
and the number of repeat motif shifts is in parentheses. ((-)) indicated a loss of repeat units,
while (+) indicated a gain of repeat units. Normal alleles are shown next to their mutated
muta
alleles. Each set of peaks is identified by the marker name and repeat motif (top row).
Shown below each peak is the size of each allele in base pair (bp). Markers were labeled
with either 6-FAM
FAM (blue) or HEX (green) fluorescent dyes.
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Figure 4.1 Continued.
Notes: Normal and mutated alleles are identified according to repeat motif shifts.
Dinucleotide markers (D10S529, D16S3034, D16S3091, D18S63, and DXS1208) show
the corresponding normal allele, as well as the mutated allele that was shifted greater
great than
2 or less than 3 repeat motifs. Mutated alleles are indicated with a red star and the number
of repeat motif shifts is in parentheses. ((-)) indicated a loss of repeat units, while (+)
indicated a gain of repeat units. Normal alleles are shown next tto
o their mutated alleles.
Each set of peaks is identified by the marker name and repeat motif (top row). Shown
below each peak is the size of each allele in base pair (bp). Markers were labeled with
either 6-FAM
FAM (blue) or HEX (green) fluorescent dyes.
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Figure 4.1 Continued.
Notes: Normal and mutated alleles are identified according to repeat motif shifts.
Tetranucleotide markers (D14S588 and D1S551) show the corresponding normal allele,
as well as the mutated allele that was shifted greater than 1 or less than 2 repeat motifs.
Mutated alleles are indicated with a red star and the number of repeat motif shifts is in
parentheses. (-) indicated a loss of repeat units, while (+) indicated a gain of repeat units.
Normal alleles are shown next to their mutated alleles. Each set of peaks is identified by
the marker name and repeat motif (top row). Shown below each peak is the size of each
allele in base pair (bp). Markers were labeled with 6-FAM (blue) fluorescent dyes.
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Figure 4.2

Histological characterizations of embryoid bodies from ES cells

Notes: A, B, and C are from EBs at 14 days after in vitro differentiation showing typical
morphology and histology characteristics of differentiated tissues from the three germinal
layers. (A) Neural epithelium characteristics in an ectoderm layer. (B) Mesenchymal
characteristics in a mesoderm layer. (C) Pseudos
Pseudostratified
tratified columnar epithelium
characteristics in an endoderm layer. Phase contrast images (left panels) are shown with
10X magnification. Haematoxylin and Eosin stained images (right panels) are shown at
60X magnification.
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Figure 4.3

Immunofluorescent characteriz
characterization
ation of embryoid bodies differentiated from
ES cells

Notes: A, B, and C are from EBs at 14 days after in vitro differentiation. (A) EB showing
βIII-tubulin
tubulin positive expression (green) which is characteristic of neuroectoderm
differentiation. (B) EB showing myosin positive expression ((red)
red) which is characteristic
of cardiac muscle (mesoderm differentiation). (C) EB showing GATA positive
expression (orange) which is characteristic of endoderm differentiation. Nuclei were
visualized with DAPI stain
ain (blue) (left panels). Fluorescence images are show in
magnification of 60X.
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Figure 4.4

Mean mutation frequencies of unstable markers across EB samples at three
points of time

Notes: (A) EBs from H1 and H7 ES cell lines showed statistically significant differences
of frequencies of unstable markers at 7 days after in vitro differentiation when compared
to frequencies of unstable markers at 30 days after in vitro differentiation (p<0.05).
Values represent the overall mean frequency of unstable markers over three points of
time. (B) Phase contrast image of EBs in suspension at 7, 14, and 30 days after in vitro
differentiation (magnification of 10X) (C) List of unstable markers at 7, 14, and 30 days
after in vitro differentiation.
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Figure 4.5

Unstable markers in embryoid bodies differentiated from H1 and H7 ES
cell lines

Notes: Differences in overall mean mutation frequencies were observed between EBs
from H1 and H7 ES cell lines. Values represent the overall mean mutation frequency of
EB sample replicates (n=144) per marker that was calculated with SP-PCR software (MD
Anderson Cancer Houston, TX). D16S3091 and IGF2-PROM markers showing a highly
statistically significance differences (p<0.001). D16S3034, D10S529, D14S588,
D11S4090, and D1S551 markers show high statistically significant differences (p≤0.05).
The D3S1583 marker did not show any significance differences (*).
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Figure 4.6

Unstable markers of embryoid bodies differentiated from H1 and H7 ES
cell lines

Notes: Statistically significant differences in overall mean mutation frequencies were
observed between EBs from H1 and H7 ES cell lines. (A) Overall mean values for
mutation frequencies of unstable markers observed in EBs from the H1 ES cell line. (B)
Overall mean values for mutation frequencies of unstable markers observed in EBs from
the H7 ES cell line. Values represent the overall mean mutation frequency of EB sample
replicates (n=144) per marker that was calculated with SP-PCR software (MD Anderson
Cancer Houston, TX). Markers show statistically significant differences p ≤ 0.05 except
for D6S2252 and D4S2623 that show marginally significant differences *p ≤ 0.10.
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Figure 4.7

Embryoid bodies from the H1 ES cell line differentiated into early
neuroectodermal tissue after 30 days

Notes: (A-B) Neural progenitor spheres with extensive cell growth around the clusters
and neurite grew radially from the middle EB sphere (black arrow heads). (B) Neural
rosettes are observed inside the floating spheres (black arrows). (C) Neural rosette with
high confluence of early progenitors that appear after 3 weeks of in vitro differentiation
from the H1 ES cell line. (D) Boxed region from C panel, shown in 60X magnification
and displays neuronal generation in the outgrowth area. Cells generated are in migration
status (white arrows). Phase contrast images (A-C) are at a magnification of 10X.
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Figure 4.8

Embryoid bodies from the H7 ES cell line differentiated into cardiac
muscle tissue (early mesoderm) 14 days after in vitro differentiation
induction

Notes: (A) EBs differentiated into mesoderm, showing characteristic morphology of a
confluent cardiac lineage. (B-C) EBs differentiated into functional mesoderm, showing
contractile cardiac muscle. Contraction rate frequency increased over time during in vitro
differentiation. (B) Initially, the rate was 50 contractions per minute (cpm) at 14 days of
in vitro differentiation induction (see supplemental file Video005). (C) Contractions
increased to 70 cpm after 30 days of in vitro differentiation induction (see supplemental
file Video007). Phase contrast images are at a magnification of 10X.
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Table 4.1

List of single tandem repeat markers analyzed in samples of embryoid
bodies from H1 and H7 ES cell lines

Notes: Ten markers were related to pluripotency genes, 33 were related to differentiation
genes, and 20 were related to imprinting genes.
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Table 4.2

Mean mutation frequencies of eight unstable markers in embryoid bodies differentiated from H1 and H7 ES cell lines
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Notes: Number of normal alleles (n),
), number of mutated alleles ((m), and mean value of mutation frequency
quency (f)
( calculated by SPPCR software with SP-PCR
PCR software (MD And
Anderson Cancer Houston, TX). *NS Indicates no statistical significance.
significance

Table 4.3

Mean mutation frequencies of seven unstable markers that displayed statistically significant differences in EBs fr
from
the H1 ES cell line compared to EBs from the H7 ES cell line
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Notes: Number of normal alleles (n),
), number of mutated alleles ((m),, and mean value of mutation frequency (f)
( calculated with SPPCR software (MD Anderson Cancer Houston, TX).

Table 4.4

Mean mutation frequencies of three unstable markers that displayed
statistically significant differences in EBs from the H7 ES cell line
compared to with EBs from H1 ES cell line

Notes: Number of normall alleles ((n), number of mutated alleles (m),, and mean value of
mutation frequency (f)) calculated with SP
SP-PCR software (MD Anderson
nderson Cancer Houston,
TX). p-value ≤ 0.05 in bold. p-value ≤ 0.10 are in italic.
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Table 4.5

List of genes associated with unstable markers

Notes: Summary of gene characteristics located in close proximity to unstable markers
involved in embryonic development. These eighteen unstable markers were identified in
EBs differentiated from H1 and H7 ES cell lines
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Table 4.5 continued
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CHAPTER V
UNSTABLE REPETITIVE SEQUENCES LOCATED NEAR GENE PROMOTER
COULD BE A SIGNAL FOR REGULATION OF GENE EXPRESSION
DURING TUMORIGENESIS
5.1

Abstract
Single tandem repeats are sequences of DNA that have been implicated in the

deregulation of gene expression in human conditions such as fragile X syndrome,
neurodegenerative diseases, and tumorigenesis. Understanding the origin of repetitive
sequence instability and functions on the genome allow us to describe early steps of
genomic instability signals in cell differentiation and tumor transformation mechanisms.
Here we show how instability in repetitive sequences located distal or proximal distances
to particular genes could be a signal for deregulation of gene expression after DNA
damage accumulation in ovarian cancer cells and normal ovarian cells. Significant
instability was shown in five single tandem repeat markers (BAT26, BAT60, D7S3046,
DXS9902, and DXS6801) nine days post-exposure to high concentrations of H2O2.
Genes located near these unstable repetitive markers were identified. Our results from
gene expression analyze reported significant up-regulation of five genes (MSH2,
CHMP4C, STAG3L4, AUTS2, and PMS2L4), and significant down-regulation of four
genes (EPCAM, ASB9, FIGF, and PCDH11X) in ovarian cancer cells in comparison to
normal ovarian cells after DNA damage. These observations are consistent with our
hypothesis that genomic instability in repetitive regions of the genome is a signal for
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differential gene expression that leads to tumor transformation and maintains cell survival
after accumulation of DNA damage. Genetic modification patterns in specific target
genes involved in tumor cell transformation are useful tools for testing tumor progression
and improving cancer therapy sensitivity.
5.2

Introduction
Developmental genes are usually deregulated during neoplastic transformation,

leading to cellular responses such as proliferation, differentiation, migration, invasion,
and angiogenesis, ensuring a perfect environment for tumor transformation (Gupta et al.
2005; Ince et al. 2007). Aggressiveness and invasiveness are fundamental characteristics
of ovarian tumor progression. Several authors suggest that the ability to metastasize
rapidly to different organs is due to developmental signals because tissues of germinal
origin are deregulated or reactivated during tumor transformation (Gupta et al. 2005;
Karakosta et al. 2005; Proia et al. 2011). Primordial germinal cells migrate into the
genital ridge, and their differentiation into the female gonad is the result of coordinated
molecular signals early in embryo development. Similarities have also been found in the
neoplastic phenotype on ovarian tumorigenesis.
Cell differentiation and tumor transformation share several molecular signaling
pathways, including gene expression and epigenetic modifications (Karakosta et al. 2005;
Proia et al. 2011). Tumor cells show losses in genome integrity due to the accumulation
of DNA damage (Fearon and Vogelstein 1990). Instability in single tandem repeats
originate frame shift mutations in coding and non-coding regions in the DNA, inducing
failures in cellular regulatory pathways such as cell cycle control, apoptosis, and DNA
repair that are responsible for avoiding cell transformation (Imai et al. 2008). We
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hypothesize that unstable repetitive regions located in the 5’untranslated region of a gene
could be the earliest molecular signal for transcription deregulation that allows
tumorigenesis. Instability and gene expression profile determination could be detectors of
initiation, progression, and prognostics for ovarian tumorigenesis.
The aim of the present study was to characterize single tandem repeat signaling,
in relation to nearby genes that induce gene expression deregulation after DNA damage
accumulation in both cancer and normal ovarian cells. Detection of five unstable
repetitive sequences in the genome allows for the identification of sixteen neighboring
possible target genes involved in ovarian tumorigenesis. Gene expression status of these
target genes was determined by real time PCR in cancer and normal ovarian cells 9 days
post-exposure to H2O2 (30µM). Gene expression deregulation was observed in genes
involved in cell stress responses, such as DNA repair, cell growth, and tumor
progression. Our results support our hypothesis that instability in repetitive regions could
be a signal of gene expression modifications that lead to tumor transformation and
progression after DNA damage accumulation.
Additionally, determination of genomic instability and gene expression
interaction aid in our understanding of the earliest steps in tumorigenesis that lead to the
impaired gene functions involved during cell transformation. Our analysis revealed five
novel candidate genes that showed gene expression deregulation after DNA damage in
ovarian cancer cells in comparison to ovarian normal cells. Identification of novel and
potential target genes provide a systematic validation of biomarkers for the
characterization of ovarian carcinoma. New therapeutic approaches are needed for
ovarian cancer treatments and understanding the mechanisms of initiation and
progression could help develop and validate new treatments in favor of the patients.
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5.3
5.3.1

Materials and Methods
Cell culture
Human cancer cell line (SKOV) was purchased from American Type Culture

Collection, ATCC (Rockville, MD) and human ovarian cell line established from ovarian
tissue removed from a normal woman. This tissue was donated for this research by
informed consent (IRB approval number 11-088). Cancer and normal ovarian cells were
cultured routinely in T-25 culture flasks (Falcon, Becton Dickinson, Labware, NJ) in
Dulbecco’s modified eagle medium (DMEM) high glucose (Invitrogen, Carlsbad, CA),
supplemented with 10% heat inactivated fetal bovine serum (Invitrogen, Carlsbad, CA),
30mg/ml of L-glutamine (Invitrogen, Carlsbad, CA), and 1% of antibiotic/antimycotic
(Invitrogen, Carlsbad, CA). Cells were maintained in a humidified atmosphere at 37°C in
5% CO2. Medium was changed every 72 hours.
5.3.2

In vitro exposure to hydrogen peroxide
When cancer and normal ovarian cells reached 80% confluency, they were

trypsinized and treated with 0 or 30µM concentration of H2O2 (Fisher Scientific,
Houston, TX) in 1X PBS (Invitrogen, Carlsbad, CA) for 1 hour in a humidified
atmosphere at 37°C in 5% CO2. Cells were then centrifuged at 1000 x g for 5 minutes.
The supernatant was removed and cells were washed twice with fresh 1X PBS. Untreated
and treated cells were then plated in triplicate at a density of 1 x 105 cells/ml and cultured
in a humidified atmosphere at 37°C in 5% CO2. Medium was changed every 72 hours
until 9 days post-exposure. Concentrations of H2O2 and determination of time postexposure was reported from previous experiments in our lab that showed increased
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mutation frequencies in specific microsatellites under these conditions (Moreno-Ortiz
2011).
5.3.3

RNA isolation
At 9 days post-exposure, cancer and normal ovarian cells were trypsinized. Cells

were then centrifuged at 1000 x g for 5 minutes, and after PBS washing, total RNA was
extracted from cell suspensions using RNeasy plus mini kit (Qiagen, Ontario, Canada)
following the manufacturer’s protocol. cDNA was synthesized by using QuantiTect
reverse transcription kit (Qiagen, Ontario, Canada) according to the manufacturer’s
recommendation. Briefly, 1µg of total RNA was treated with DNA wipeout buffer for 2
minutes at 42°C, Quantiscript reverse transcriptase master mix was added to the RNA
sample and incubation was carried out at 42°C for 30 minutes, followed by incubation at
95°C for 3 minutes to inactivate the reaction. cDNA samples were stored at -20°C until
real time PCR was performed.
5.3.4

Real time PCR
Real time PCR was performed to assess transcripts of 16 genes that are in, or

near, five unstable single tandem repeat markers that previously showed high mutation
frequencies in these ovarian cell lines (Moreno-Ortiz 2011). The validated primer sets,
QuantiTect primer assays, were used for the genes EPCAM, MSH2, ASB9, ASB11,
FIGF, PIR, E2F5, CA2, CHMP4, FABP4, PAG1, STAG3L4, PMS2L4, AUTS2,
PCDH1X, and NAP1L3 (Qiagen, Ontario, Canada) (Table 5.1). All primers were
designed to span exon - intron boundaries to avoid non-coding genomic DNA
amplification (Qiagen, Ontario, Canada). Expression changes of genes were evaluated in
relative expression with respect to the gene β-Actin (ACTB). RNA amplification was
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performed with 2µl of cDNA samples and detected by QuantiFast SYBR Green PCR kit
(Qiagen, Ontario, Canada). Primer concentration used was 1µM. Real time PCR was
performed in an ABI Prism 7000 sequencer detector (Applied Biosystemss, Foster City,
CA) using the following protocol: 1 cycle of 95°C for 5 minutes for initial activation
step, and 40 cycles of two step cycling 95°C for 10 seconds for denaturation and 60°C for
30 seconds for combined annealing/extension steps. A melting curve was performed
starting at 55°C with a 0.5°C increased over 10 seconds in 80 cycles. Negative controls
(no cDNA) were included to check for contamination and positive controls of the ACTB
housekeeping gene were included as an amplification control. Reactions were replicated
three times for each sample.
5.3.5

Real time gene expression statistical analysis
Real time PCR data was calculated using the comparative CT method

(2-∆∆CT method) between target genes and the internal control gene per sample
(Schmittgen and Livak 2008). The data is reported as a gene expression fold change due
to H2O2 exposure on ovarian cancer and ovarian normal cell lines. Differences in gene
fold change values after treatment were calculated and analyzed with a two tailed t-test
using a statistical package SAS/win 9.2 (SAS Institute, Cary, NC). Gene expression
changes were considered statistically significant when the p value was ≤0.05 and were
considered marginally significant if the p value was ≤0.10.
5.4
5.4.1

Results
Chromosome location of unstable markers and neighboring genes
Five single tandem repeat markers that showed high frequencies of instability

were previously selected in our lab (Moreno-Ortiz 2011). We determined the genomic
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distance in mega bases (Mb) of the neighboring genes located upstream or downstream of
each unstable marker. We identified sixteen genes associated with these particular
unstable markers (Table 5.1). Marker BAT26 has two genes upstream from it (EPCAM
and MSH2) (Figure 5.1), marker BAT60 has three genes upstream from it (CHMP4C,
FABP4, and PAG1) in addition to two genes downstream from it (E2F5 and CA2)
(Figure 5.2). Marker DXS9902 has four genes upstream from it (ASB9, ASB11, FIGF,
and PIR) (Figure 5.3), Marker D7S3046 has two genes upstream from it (STAG3L4 and
PMS2L4) in addition to one gene located downstream from it (AUTS2) (Figure 5.4).
Marker DXS6801 has two genes located downstream from it (PCDH11X and NAP1L3)
(Figure 5.5).
5.4.2

Instability is a signal of gene expression changes in ovarian cells
Determination of genomic instability in single tandem repeats is a normal

molecular pathway studied widely during tumorigenesis (Boland et al. 1998; Berg et al.
2000). We were interested in determining whether instability found in single tandem
repeats located near specific genes could be the signal of gene expression changes after
DNA damage in ovarian cancer cells. To identify novel genes that contribute to the
malignant progression of ovarian carcinoma, normal and cancerous ovarian cells were
treated with a high concentration of H2O2 (30µM) as a source of DNA damage.
Instability was found in five single tandem repeat markers (BAT26, BAT60, D7S3046,
DXS9902, and DXS6801) after 9 days post-exposure. This approach revealed sixteen
distinct genes that were near the unstable markers found previously in our lab. We
evaluated by real time PCR two DNA repair genes (MSH2 and PMS2L4), four genes
involved in cell growth pathways (FIGF, EPCAM, CHMP4C, and PCDH11X), two genes
164

associated with tumorigenesis and metastasis (ASB9 and STAG3L4), and one candidate
gene for autism (AUTS2). A total of nine out of sixteen genes showed differential
expression (EPCAM, MSH2, CHMP4C, ASB9, FIGF, STAG3L4, AUTS2, PMS2L4, and
PCDH11X) (Table 5.2) in ovarian cancer cells in comparison with normal ovarian cells
in response to DNA damage accumulation. These results showed a differential expression
on more than 1.5 fold higher expression changes in tumor ovarian cells relative to the
normal ovarian cells. Non-significant differences in gene expression were shown in seven
genes associated with unstable repetitive sequences after H2O2 exposure (E2F5, CA2,
FABP4, PAG1, ASB11, PIR, and NAP1L3). Our results suggest that instability in
markers located in close proximity to target genes could be an early signal for differential
expression during ovarian cancer evolution.
5.4.3

DNA repair genes deregulate as a cause of instability of the upstream single
tandem repeats
Microsatellite instability has been associated with colon cancers resulting from

deficiencies in DNA repair mechanisms, specifically in mismatch repair (MMR) proteins
(Thibodeau et al. 1993; Boland et al. 1998). In ovarian cancer, MMR deficiencies are
involved in tumor initiation (Begum et al. 2008; Yoon et al. 2008). We asked if
instability of repetitive sequences located upstream from the DNA repair genes could be
deregulated in normal ovarian and cancerous ovarian cells after H2O2 exposure.
Consequently, we detected instability in two markers (BAT26 and D7S3046) located
upstream from MSH2 and PMS2L4, which are DNA repair genes responsible for MMR
mechanisms after DNA damage. Significant gene expression changes were found in these
genes after 9 days post-exposure (Table 5.2). The MSH2 gene showed increased
expression in cancerous ovarian cells compared to normal ovarian cells (p= 0.059)
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(Figure 5.6). Additionally, the PMS2L4 gene showed increased expression in cancerous
cells compared to normal cells after H2O2 exposure (p=0.003) (Figure 5.6). Significant
differential gene expression was found in two MMR proteins and could be a mechanism
for ovarian tumorigenesis.
5.4.4

Genes involved in cell growth signals are expressed differentially in ovarian
cancer cells
Cell survival, invasion, angiogenesis, and migration are characteristics of

tumorigenesis. We asked if instability in the markers DXS9902, BAT26, BAT60, and
DXS6801, which are located in the neighboring regions of cell growth regulator genes,
induced gene expression changes that are involved during tumor initiation and
progression. We found differential expression in four genes involved in cell growth
pathways (FIGF, EPCAM, and PCDH11X, and CHMP4C). FIGF, EPCAM, and
PCDH11X were down-regulated in both cancerous and normal ovarian cells after
exposure (Table 5.2). Up-regulation was observed in the CHMP4C gene due to H2O2
exposure in ovarian cancer cells compared to normal ovarian cells (p= 0.023) (Figure
5.7). Cell growth mechanisms become imbalanced by genomic instability and gene
expression changes resulting for accumulation of DNA damage in cancerous and normal
ovarian cells.
5.4.5

Instability is present in markers linked to deregulated genes involved in
intracellular signals during tumorigenesis
Aggression and invasion are main characteristics of carcinomas with poor

prognosis. Deregulation of particular genes lead to ovarian cancer evolution. Cellular
homeostasis is crucial in resistance to tumor treatment. Our study was designed to
determine if instability in markers DXS9902 and D7S3046, located near the ASB9 and
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STAG3L4 genes, is a signal for differential gene expression after H2O2 exposure of
cancerous and normal ovarian cells. We found that tumor and normal ovarian cells
displaying instability in single tandem repeats located upstream of ASB9 gene, also
displayed significant down-regulation of this gene after DNA damage (p=0.013) (Figure
5.8). In contrast, the STAG3L4 gene that is located downstream of the repetitive region
showed significant up-regulation in cancerous ovarian cells compared with normal
ovarian cells after 9 days post H2O2 exposure (p=0.003) (Figure 5.8). Taken together,
these results indicate that gene expression changes are present after DNA damage and
could signal of cell survival.
5.4.6

AUTS2 gene is deregulated during ovarian cancer
The repetitive marker D7S3046 was unstable in ovarian cancer cells and is

located upstream of the autism susceptibility candidate 2 (AUTS2) gene. This gene has
been studied in patients with bipolar schizoaffective disorder, autism, and attentiondeficit/hyperactivity disorder (ADHD) (Sultana et al. 2002; Hamshere et al. 2009). No
report has linked this gene to cell transformation or tumorigenesis. The AUTS2 gene
showed significantly increased up-regulation in ovarian cancer cells after 9 days post
H2O2 exposure (p=0.09) (Figure 5.9). We speculate that this gene could be involved
during early neural development but can be deregulated and targeted for involvement
during cell differentiation and tumor transformation (Sultana et al. 2002; Gratacòs et al.
2009).
5.5

Discussion
Ovarian carcinomas start on the external epithelial layer, and then cortical

inclusions move it to the internal epithelium through the formation of cysts. Ovarian cells
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gradually acquire a series of genomic abnormalities leading to invasive tumors.
Carcinomas result from disruption of the gene complex responsible for cellular DNA
damage response. These and other stress response genes play a role in different cellular
functions including development, differentiation, and tumor transformation. The origin
and pathogenesis of ovarian tumorigenesis is poorly understood.
Unraveling the complex molecular regulatory systems should allow better
understanding of the signals that could trigger ovarian carcinogenesis. Analysis of single
tandem repeat instability combined with real time PCR is an approach to identify novel
genes involved in ovarian tumor initiation and progression. Our study showed that
instability in single tandem repeat markers located near particular genes could be the
signal of gene expression changes observed in cancerous and normal ovarian cells after
DNA damage. We identified nine novel target genes involved in stress responses during
ovary tumor formation (ASB9, PMS2L4, MSH2, AUTS2, STAG3L4, EPCAM, FIGF,
PCDH11X, and CHMP4C). Genes identified play roles in cellular processes including
cell survival, DNA repair, and growth signals. Normally, DNA sequences have noncoding regions called heterochromatin that are responsible for chromosomal integrity.
These specific regions are targets for genomic instability after DNA damage
accumulation in the cells. All genes identified in our study have an unstable repetitive
sequence upstream of the gene start site, which may be the mechanism that triggers
differential expression by regulatory elements involved in transcriptional deregulation
during tumorigenesis (Panne et al. 2007; Kuwabara et al. 2009; Montoya-Durango et al.
2009).
We hypothesized that genomic instability could be the signal that regulates gene
expression in specific genes responsible for cell cycle, differentiation, and cell growth
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pathways during tumor transformation. Our results demonstrated that instability in both
proximal and distal repetitive sequences upstream or downstream of specific genes could
be the signal for deregulation of gene expression. Several studies report the presence of
regulatory elements localized in neighboring genes as enhancer or repressor sequences
responsible for transcription modulation (Panne et al. 2007). Regulatory elements are
located upstream or downstream of transcription start sites. Some authors report that they
are within a 5 kb distance, while others report distances up to 1 Mb (Lettice et al. 2003;
Kleinjan et al. 2006; Visel et al. 2009). We suggest that instability in single tandem
repeats could be a regulatory element signal important in cell differentiation and tumor
transformation. Misbalance of gene expression is a signal for ovarian tumor invasion,
metastasis, and resistance of cancer cells in vivo. For example, our data indicates that
marker DXS9902, a proximal unstable repeat marker located 0.03Mb from the promoter
region of ASB9 gene, induces ASB9 differential gene expression after DNA damage in
ovarian cancer cells. The Ankyrin repeat and SOCS box-containing 9 (ASB9) gene is an
E3 ubiquitin ligase that mediates the degradation of proteins. This gene is a prognostic
indicator in patients with colorectal cancer. Low expression of ASB9 is associated with
increased invasiveness and poor prognostics (Tokuoka et al. 2010). In addition, ASB9 is
responsible for regulation of proliferation and differentiation when it interacts with the
creatine kinase system, which negatively regulates cell growth (Kwon et al. 2010).
Specifically, in ovarian cancer, the Ankyrin gene has been directly associated with
aggressiveness of the tumor and poor prognostics (Scurr et al. 2008). Down-regulation of
the ankyrin gene is a strategy to improve the treatment outcome by the induction of
chemotherapy sensitivity in patients with ovarian cancer (Scurr et al. 2008).
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DNA damage triggers different cellular pathways, including DNA repair, that
involve large numbers of genes. MMR deficiency was identified initially as a potential
cancer initiating pathway in colon cancer but nowadays is also linked to several other
cancers, including ovarian and endometrial cancer (Thibodeau et al. 1993; Boland et al.
1998; Yoon et al. 2008). The MMR complex is formed by MLH1, MLH3, MSH2,
MSH3, MSH6, PMS1, and PMS2 proteins. MMR proteins are intimately involved in
maintaining genomic integrity by repairing nucleotides losses or gains in single tandem
repeat motifs across the genome after DNA damage. DNA repair mechanisms are
differentially regulated in ovarian cancer cells by silencing MLH1 through
hypermethylation (Swisher et al. 2009). Differential repair responses in the gene
expression of MMR proteins such as MSH2 and PMS2 were observed in ovarian cancer
cells. We found changes of expression in these two important MMR genes in our cancer
cells after H2O2 exposure compared to normal cells. Normal ovarian cells showed no
expression of MSH2 and PMS2L4, suggesting that normal cells may be defective in the
ability to repair the sequence of unstable DNA sequences after H2O2 exposure. The MutS
homolog 2, colon cancer, nonpolyposis type 1(MSH2) gene has been widely linked to
tumorigenesis. When MMR genes are deregulated, DNA damage accumulation occurs in
the cells, contributing to tumor initiation and progression (Boland et al. 1998). In addition
to MSH2, we found that changes in differential expression in the postmeiotic segregation
increased 2 pseudogene 4 (PMS2L4) gene that is involved in DNA repair mechanisms.
Mutations in the PMS2 genes are characteristic of tumorigenesis. Germline mutations are
associated with lymphomas and neuroectodermal tumors in children (Hendriks et al.
2006). Our results indicate that instability in repetitive regions near DNA repair genes are
responsible for gene expression deregulation after DNA damage accumulation.
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The STAG3L4 and CHMP4C genes show differential expression changes in
genes involved in cell growth, as well as intracellular signals that regulate cellular
processes. The Stromal antigen 3-like 4 (STAG3L4) gene is a meiosis specific
cohesion that stabilizes sister chromatid cohesion protein (Prieto et al. 2004). Allele
specific imbalances of the STAG3 gene in primary epithelial ovarian tumors by single
nucleotide polymorphism (SNP) have been reported (Notaridou et al. 2011). In
lymphomas, this gene is inactivated after irradiation exposure (Kalejs et al. 2006).
Chromosomal instability in colon and testicular cancer has been linked to STAG3 gene
mutations (Skotheim et al. 2005; Barber et al. 2008). In our study, this gene was upregulated in ovarian cancer cells after DNA damage due to H2O2 exposure compared to
with normal ovarian cells that did not show expression of this gene. The chromatin
modifying protein 4C (CHMP4C) gene is involved in endosomal degradation of
receptors. For example, it is responsible for degradation of the epidermal growth factor
(EGF) receptor (Bowers et al. 2006). This gene is possibly involved in stress responses
through interaction with the p53 protein that prevents accumulation of DNA damage by
regulating cell growth. The CHMP4C transcript is regulated by the p53 protein,
enhancing exosome production that induces a quick degradation of epidermal growth
factor receptors from the plasma membrane (Katoh et al. 2004; Yu et al. 2009). Our
report is the first documentation of CHMP4C gene up-regulation during ovarian cancer
development as a co-modulator of the p53 tumor suppressor pathway.
In conclusion, the mechanisms underlying gene expression deregulation of ASB9,
PMS2L4, MSH2, STAG3L4, and CHMP4C in ovarian tumors still needs to be
elucidated. Our observation of differential expression may indicate epigenetic
modification play a role in gene silencing or in activation by methylation and histone
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changes during DNA damage response signals during ovarian tumorigenesis. We used a
functional approach to study whether genomic instability, is an early disruptor of gene
expression, leads to cellular differentiation and the development of ovarian carcinomas.
This approach allows the identification of novel gene candidates, useful for diagnostics
and prognostics of ovarian cancer. Our results add to the elucidation of functional genetic
events that may induce ovarian carcinoma progression and offers potential biomarkers for
cancer testing.
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Figure 5.1

BAT 26 single tandem repeat marker

Notes: (A) Marker location on chromosome 2 (2p22-p21) (open red box). (B) Repeat
motif of marker BAT 26 (A)26 (filled blue box) and two genes located downstream (open
blue boxes). The name of the genes and the associated distance in mega bases (Mb) from
the marker is shown below each gene.
(http://www.ensembl.org/Homo_sapiens/Location/View?r=2%3A47494991-47495112)

Figure 5.2

BAT 60 single tandem repeat marker

Notes: (A) Marker location on chromosome 8 (8q21) (open red box). (B) Repeat motif of
marker BAT 60 (A)60 (filled blue box), three genes located upstream (open blue boxes
on the left), and two genes located downstream (open blue boxes on the right). The name
of the genes and the associated distance in mega bases (Mb) from the marker is shown
below each gene.
(http://www.ensembl.org/Homo_sapiens/Location/View?r=8%3A83732830-83733122)
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Figure 5.3

D7S3046 single tandem repeat marker

Notes: (A) Marker location on chromosome 7 (7q21.1) (open red box). (B) Repeat motif
of marker D7S3046 (GATA)12 (filled blue box), two genes located upstream (open blue
boxes on the left), and one gene located downstream (open blue box on the right). The
name of the genes and the associated distance in mega bases (Mb) from the marker is
shown below each gene.
(http://www.ensembl.org/Homo_sapiens/Location/View?db=core&r=7%3A6655198569552321)

Figure 5.4

DXS9902 single tandem repeat marker

Note: (A) Marker location on chromosome X (Xp22.31) (open red box). (B) Repeat motif
of marker DXS9902 (AGAT)10 (filled blue box) and four genes located downstream
(open blue boxes). The name of the genes and the associated distance in mega bases (Mb)
from the marker is shown below each gene.
(http://www.ensembl.org/Homo_sapiens/Location/View?r=X%3A15233537-15233708)

174

Figure 5.5

DXS6801 single tandem repeat marker

Note: (A) Marker location on chromosome X (Xq21.32) (open red box). (B) Repeat motif
of marker DXS6801 (ATCT)10 (filled blue box), one gene located upstream (open blue
box on the left), and two genes located downstream (open blue boxes on the right). The
name of the genes and the associated distance in mega bases (Mb) from the marker is
shown below each gene.
(http://www.ensembl.org/Homo_sapiens/Location/View?db=core&r=X%3A9151130193551172)
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Figure 5.6

Changes in expression of DNA repair genes

Note: Real time PCR for PMS2L4 and MSH2 genes. Nine days after H2O2 exposure,
total RNA was extracted from normal and cancerous cells, reverse transcribed, and
amplified with specific primers per gene. Quantitative data were normalized to the level
of the housekeeping gene ACTB. Error bars show SD, (n=3) *p<0.05. The table below
the graph shows the fold change values of gene expression per sample and gene. Fold
change was calculated using the comparative CT method.
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Figure 5.7

Changes in expression of genes responsible for cell growth.

Note: Real time PCR for FIFG, EPCAM, PCDH11X, and CHMP4C genes. Nine days
after H2O2 exposure, total RNA was extracted from normal and cancerous cells, reverse
transcribed, and amplified with specific primers per gene. Quantitative data were
normalized to the level of the housekeeping gene ACTB. Error bars show SD, (n=3)
*p<0.05 **p<0.10. The table below the graph shows the fold change values of gene
expression per sample and gene. Fold change was calculated using the comparative CT
method.
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Figure 5.8

Changes in expression of genes involved in tumorigenesis and one gene
candidate for susceptibility of autism

Notes: Real time PCR for ASB9, ATAG3L4, and AUTS2 genes. Nine days after H2O2
exposure, total RNA was extracted from normal and cancerous cells, reverse transcribed,
and amplified with specific primers per gene. Quantitative data were normalized to the
level of the housekeeping gene ACTB. Error bars show SD, (n=3) *p<0.05 **p<0.10.
The table below the graph shows the fold change values of gene expression per sample
and gene. Fold change was calculated using the comparative CT method.
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Table 5.1

List of genes evaluated by real time PCR

Notes: Sequences of the prim
primers are available in
https://www.qiagen.com/geneglobe/qtprimerview.aspx
https://www.qiagen.com/geneglobe/qtprimerview.aspx?
Table 5.2

Changes in gene expression for normal and cancerous ovarian cells

Notes: Fold changes were calculated using the comparative CT method. P-values
P
≤ 0.05
(bold) p<0.10 (italic)
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TANDEM REPEAT MOTIF LOCATED IN PROXIMAL PROMOTER REGIONS OF
PLURIPOTENCY, SELF-RENEWAL, AND DIFFERENTIATION GENES
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APPENDIX B
H1 (WA01), H7 (WA07) HUMAN EMBRYONIC STEM CELL LINES AND MEF CF1 MOUSE FIBROBLAST CELL LINE INFORMATION AND CERTIFICATES OF
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APPENDIX C
SP-PCR SOFWARE VERSION 2.0 FROM M.D. ANDERSON CENTER
INTRUCTIONS AND MUTATION FREQUENCIES REPORTS
(http://www.hkasoftware.com/index.php?object=SPPCR)
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Documentation at http://www.hkasoftware.com/index.php?object=SPPCR, is a
continuation.
SPPCR 2.0
The Final Frontier
Table of content
1) Intro
2) Synopsis
3) Input format and meanings
3a) Assumption about input
4) Output format and meanings
5) Known problems
6) Frequently Asked Questions
218

1) Intro
In the course of every program's life, it must be ported. To a new and better language,
operating system, or platform. SPPCR 2.0 is a complete port, with bug fixes throughout,
of Barry W. Brown's SPPCR 1.0.

2) Synopsis
The general use for this program is to calculate what we presume the actual ge, the
mutation frequency, and the significance of a given data set, or pair of data set.

3) Input format and meanings
When using this program as a tool from Excel/Filemaker or other programs that export
via applescript or what-have-you, you need to give it an initial argument of 4.The initial
argument allows the program to be run several different ways, and allows me to give
several types of specific, need-based output.
current initial arguments are:
0 - do nothing
2 - run hardcoded test data to test the program and make sure it is running
3 - interactively input data by hand responding to command prompts.

example:
Enter the number of runs (number of dna amounts):2
Enter the number of alleles seen:5
Enter the sizes of the 5 alleles:140 142 144 146 148
Enter the size of the 2 progenitor alleles. If the subject
is homozygous, enter the size of the 1 progenitor twice.144
144
For each run, enter the expected genomes.
Expected ge for run 1:.8
Expected ge for run 2:.4

For each run, enter the number of replicates.
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Replicates for run 1:

and so on. Terminology that the program used is all explained at the end of this section,
as well as above the prompts.

4 - read in data in the following format:
Num runs
Num alleles
allele sizes (there needs to numallele of them)
progenitor allele's sizes, there needs to be 2 of them, if homozygous, repeat it twice
then, for each run/row
a) observed/expected ge
b) number of replicates
c) number of alleles saw at each allele size

example:
4 2 19 144 146
166

168

154

156

170

148
172

150
174

152
176

154
178

156

158

160

162

164

180

0.81 96 0 0 0 1 1 52 53 0 0 0 0 0 0 0 0 0 0 0 0
0.58 32 0 0 0 1 2 15 11 0 0 0 0 0 0 0 0 0 0 0 0

Now lets look at this in details. 4 means we are using this format of input/output. The 2
means there are 2 different runs being looked at. The next number states that there at 19
possible allele sizes that have observed alleles in them. The next 19 numbers are of
course the allele sizes. 154 and 156 are the 2 progenitors in this case.
After that, we have our first run, which has an expected ge of .81, 96 replicates, and the
next 19 numbers are the observed alleles. Our second run has an expected ge of .58 and
32 replicates, and the next 19 numbers are of course the observed allele.

5 - This is the quiet version of option 6. It is used to calculate significance between 2
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frequencies. The format to pipe your data in is:
Frequency 1
Frequency 2
Standard Error 1
Standard Error 2

6 - Like option 5, this will calculate the significance, but it is intended for interaction
between the user and it. Just follow the prompt.
Enter the first mutant frequency: .046
Enter the second mutant frequency: .047
Enter the first standard error: .003
Enter the second standard error: .0042

7 - exactly like option 4, but has a verbose output
terminology:
run: A PCR experiment at one sample
allele size: PCR fragment size
replicates: number of wells examined
expected ge: what you think you put into the reaction
progenitors: parental alleles

3a) Assumptions about input
a) The first input to the program must be a single character, preferably of the numerical
type from 0-6
b) At least one progenitor has been seen.

4) Output format and meanings
The computations are made for the whole. Meaning that if you do 4 runs, the ge and
frequencies are calculated as if all the runs were one giant single run.
for mode:
2 - The output to the hardcoded data should be just a standard listing. It changes from
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build to build so that the developer may fine tune aspects and perhaps even discover
bugs. It is not intended for the consumer's use.
3 - d0 = 0.7106
The d0 is an antiquated statistical output used for legacy reason (hangover from sppcr 1.0
and previous incantations). In sppcr 2.0, the ge is already calculated for you.
95% CI (0.6417,0.7961)
This the the 95% Confidence Interval for the d0.
The 1/d0 and the confidence interval for that are exactly what they sound like.
estimated ge for run 0 = 1.0555
This is the statistically calculated estimate of what the ge is.
Mutant Frequency
estimate: 0.016160
bootsrap SE: 0.004675
This is gives the mutant frequency, and the resampled bootstrap error (to be used to
determine the significance between 2 mutant frequencies)
4 - Since this is used strictly for connecting with outside programs via piping, this only
outputs <# of runs> G.E.s, followed by the mutant frequency, followed by the standard
error.
5 - Returns 1 number, that being your significance.
6 - The Z value is the statistical Z value used. If you wish to use a standard lookup table
to confirm yourself, you can. If you are a normal person, and expect this program to do
everything for you, it does. The calculated significance is provided on the next line.
Z = -0.193746
significance = 4.231874E-01
5) Known Problems
• Does not give proper results in the event of double progenitor loss. Single progenitor
loss appears to have correct results, but it has not been thoroughly tested.

6) Frequently Asked Questions
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Q) I have inputted several runs, each with the same expected ge, but different overall
traits. Why do I get the same ge for all my runs?
A) The program calculates all "runs" as a single experiment. What you are seeing
is the ge for all the runs together. If you wish to obtain a better estimate of the ge, do each
rune individual.
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